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Abstract: . Quality control in granting patents is a strong concern nowadays because 
granting patents without effective quality control will lead to negative spillover effects on 
competition, innovation, and the economy and adversely affect the public interest. More 
often than not, patent quality suffers from a poorly conducted examination process arising 
from lack of resources and information. Further, overburdened patent offices are another 
factor in low-quality patents. Pre-grant and post-grant opposition help in overcoming these 
problems by allowing third parties or interested persons to monitor patentability subject 
matters. Only innovations with valuable technology are worthy of receiving exclusive 
protection under patent law. Because each type of opposition has its relative merits and 
demerits, a country that wants to adopt the opposition process must take all factors into 
account including its domestic patent law. Thailand is one of the developing countries 
located in South East Asia that has adopted a pre-grant opposition system. In place for 
several years, it has seen plenty of oppositions and patent application appeals. This article 
considers the efficiency of the pre-grant opposition process in decisions of the Thai Board 
of Patents. An in-depth examination and analysis undertaken in the article points to the fact 
that although patent quality is in the eye of the beholder, pre-grant opposition proceedings 
in Thailand, when incorporated in legislation, increase patent quality, in return bettering 
innovation for the public benefit. 
1. Introduction  
Patent quality is of concern when granting a patent since patents can affect trade and competition in the 
market in several ways. If a patent office grants a patent to an uncomplicated invention, and the patent 
holder abuses his patent right by forbidding others from reproductions of such inventions/products, 
consumers who need to use such products will have to buy the product from only one vendor. Finally, 
that vendor will dominate the market. It can set up price for goods and exclude competitors from trading 
in the same market. The result is even worse in the case of pharmaceuticals because the sole owner of a 
patented medicine can fix prices as high as it wishes. When the price of medicine is high, poor or even 
many middle class people in developing countries cannot afford to pay for the drug. As a consequence, 
people who cannot access the required medicine will fall sick and disease mortality rates will increase. 
Therefore, patent quality has a tremendous influence on matters of public health and safety, with 
particular ramifications on underdeveloped and developing countries. The patent opposition procedure 
exists not only to protect the right of interested persons to claim novelty in their inventions but also to 
allow patent offices to examine whether an invention possesses novelty, an inventive step, and industrial 
applicability. Moreover, the patent opposition process also considers patent quality, which can prevent 
many problems that would otherwise ensue. 
The patent opposition procedure was introduced in Thailand in 1979 following international treaties. 
Thailand chose to adopt a pre-grant opposition procedure, which has proved greatly useful to the patent 
registration system in Thailand, as evidenced in several decisions of the Board of Patents as explored in 
the following. First, the author introduces the importance of patent quality and the patent oppositions 
system in Thailand as background for an analysis of the trends and effectiveness of patent opposition in 
numerous decisions of the Board of Patents and the Central Intellectual Property and International Trade 
Court, including the Supreme Court. A thorough explanation of the pre-grant and post-grant opposition 
system then follows prior to an overview of the patent system in Thailand. An understanding of the patent 
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opposition system is essential in order to analyze how it benefits Thailand, especially regarding improved 
patent quality. Consequently, readers will understand the system of patent opposition in Thailand and its 
advantage as a whole. 
1.1 Introduction to Patents 
A patent is a monopoly right granted to the inventor/applicant to protect various types of 
inventions/discovery. The requirements for granting patents are laid down in TRIPS. Any member 
country having enacted patent legislation must comply with the treaty. Generally, a patentable subject 
must be a subject matter that (1) is novel/new, (2) has an inventive step/is non-obvious, and (3) is capable 
of an industrial application/useful.1 Once a patent is granted, it gives monopoly right against all others in 
making, using or selling the invention for the duration of the patent, which lasts a maximum of 20 years 
from the date of the application.2 As for the general procedure in national or regional patent offices, once 
a patent application is submitted, the offices shall (1) determine that the novelty possessed by the 
innovation as referred to in the application did not exist before the date it was filed and (2) confirm via 
review of prior art3 that details appearing in the application are not similar to any information contained 
in prior patents. Subsequently, having passed the first stage, the approved application will pass to the 
examination process.4 Examiners then consider the patentability of the application. If the application 
passes the examination process, it will be published in patent journal as a granted patent. Third parties 
may bring opposition either before or after the examination process depending on patent registration 
system.  
It must be noted that examiners play an important role in examining the patentability requirements, 
particularly as to whether the innovations are up to standard and valuable enough to monopolize a 
particular field of science and thereby restrict the benefit to the public from the innovations for 20 years, 
as the patent for the Microsoft Windows© operation system’s automatic shutting down has done.5The 
criteria of “having an inventive step/non-obvious” and “capable of an industrial application/useful” are 
very subjective and depend on the examiner’s opinion. A certain innovation may be granted a patent in 
one country but may be rejected in another. The opposition process eases the task of examiners by 
allowing third parties to bring useful information related to the application, such as prior art inaccessible 
to under-resourced or overburdened examiners. In order to improve the quality of a patent, the opposition 
process is necessary.  
1.2. Patent Quality: Causes for Concern 
The patent applicants, their competitors, lawyers and patent offices are greatly concerned about patent 
quality since the grant of a patent has spillover effects on the economy, public interest, business 
entrepreneurs, competition and development of innovations.6 As a patent gives an absolute right to 
patentees for 20 years, it can lead to monopolization of inventions, which can obstruct the opportunity of 
other innovators to receive patents for similar innovations. Low quality patents should be revoked for 
public interest.  
                                                 
*The author feels greatly indebted to the Legal Office of the Department of Intellectual Property, Ministry of 
Commerce of Thailand who has kindly provided all recorded decisions of the Board of Patents from its beginning 
until now to the author. 
1
 Regarding the differences in language between requirements of patentability in US Patent law and UK Patent Act 
See P. Torremans, Holyoak & Torremans Intellectual Property Law, 5e, Oxford: Oxford University Press, 2008, p.53, 
and The Patents Act 1977 (as amended) <http://www.ipo.gov.uk/patentsact1977.pdf > accessed 14 December 2011, 
and United States Patent and Trademark Office (USPTO), Patentability, 
<http://www.uspto.gov/web/offices/pac/mpep/documents/2100.htm#chap2100> accessed 24 December 2011 
2
 W. Cornish and D. Llewelyn, “Intellectual Property: Patents, Copyright, Trade Marks and Allied Rights, 5e, 
London: Sweet & Maxwell, 2003, p.7 
3
 “Prior art means anything published before a filing date of patent which describes the same or a similar invention.” 
(Arnound Engelfreit, an IT lawyer) 
4
 C. Dent, Decision-making and quality in patents: an exploration [2006] 28 EIPR 381 at 381 
5
 Gruener, Wolfgang,  ConceivablyTech, “Microsoft Patent Operating System Shutting Down”, September 1, 2010, 
<http://www.conceivablytech.com/2530/products/microsoft-patents-operating-system-shutdown#idc-container> 
accessed  20 March 2012 
6
 T.H. Stanton et al., US Patent and Trademark Office: Transforming to meet the Challenges of the 21st Century, 
Washington, DC: National Academy of Public Administration, 2005 p. xxii 
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Jacques Combeau concluded the definition of quality patents as “valid patents which may be reliably 
enforced in court, consistently expected to surmount validity challenges and dependably employed as 
technology transfer tool”.7 As such, patents of low quality generally do not involve inventive 
technological advancements, have the propensity to face legal challenges,8 and cannot be reliably 
enforced in court. Moreover, low quality patents exploit the patent system by enabling the filing of low-
probability but high-cost applications, leading to private enforcement schemes and revocation.9 The 
consequences of low patent quality adversely impact the public interest due to costs involved in the 
granting of low quality innovations, raising monopolization of innovations, the degradation of 
technological impact and the cost of litigation involved in invalidating such patents. Consumers generally 
pay the cost. The economy also suffers since low-quality patents limit competition. Nonetheless, private 
interest tends to override public interest, negating the very purpose of the patent system. 
As mentioned by Malackowski and Barney, “Patent quality is often believed to be in the eye of the 
beholder”.10 It is difficult to prove whether patent quality is high or low given that people have different 
standards in judging novelty. Nonetheless, merely trivial improvements and dubious inventions 
demonstrate low-quality patents. Examples of infamous low-quality patents are those for “one-click 
online payment system”11 and “peanut butter and jelly sandwich.”12 If not obvious, these inventions show 
steps whose inventiveness is dubious.  
Another method to evaluate patent quality is to compare the ratio of patents granted to patent 
applications in national or regional offices. Data analysis seems to indicate that patent offices around the 
world are approving a higher number of applications than in the past.13 For example, the USPTO official 
statistics from 2001 to 2004 show that it has approved 70 percent of applications14 and the number of 
patent applications has risen every year, with a notable increase in 2010.15 The number of patents granted 
in Japan also increased by 23 percent from 2007 to 2010.16 With the use of accelerated patent examination 
systems in many patent offices, such as the US Patent and Trademark Office (USPTO) and the Japan 
Patent Office (JPO), the issue of patent quality has become crucial. Moreover, the USPTO spends 
approximately 61 months in total on average patent application for the whole patent procedure.17 More 
than 1.2 million applications were pending at the end of 2009.18The USPTO devotes a great amount of 
time to the examination process to make sure that the patents it grants are worthy. The opposition process 
can help the workload of examiners and shorten the examination period by serving as the first scan for 
prior arts to test for novelty and inventive step patentability.  
Below is a graph demonstrating the percentage of patents granted from 2001 to 2010 in three major 
patent offices: the USPTO, the JPO, and the European Patent Office (EPO). Apart from the EPO, the 
grant of patents is on the rise. From 2005 to 2010, the JPO continuously increased its grants of patents, as 
                                                 
7
 Jacques Combeau, Patent Quality: What do you mean? Amsterdam: FICPI/AIPLA Colloquium, 2007, 
<http://www.ficpi.org/library/07AmsterdamColloqu/5-Combeau_revised.pdf> accessed  14 December 2011 
8
 T.H. Stanton, op. cit., p.62  
9
 Wagner, R. Polk, Understanding Patent Quality Mechanisms, Draft of January 6, 2009,  < 
http://www.ftc.gov/bc/workshops/ipmarketplace/apr17/docs/rwagner2.pdf> accessed 15 December 2011 
10
 J. E. Malackowski and J.A. Barney, What is Patent Quality? A Merchant Banc’s Perspective, Les Nouvelles, June 
2008, p. 123 
11T.H. Stanton, op. cit., p.62   
12
 J. E. Malackowski and J.A. Barney, op. cit., p. 124 
13
 J.R. Thomas, Does Patent Quality Matter? Washington, DC: IPO Conference, 2004, p.1 
<http://www.ipo.org/AM/Template.cfm?Section=IPO_Patent_Quality_Conference&Template=/CM/ContentDisplay.
cfm&ContentID=8712> (14/12/2011) 
14
 J.R. Thomas, op. cit. 
15
 In 2010, the number of patent granted by the USPTO was approximately 46.96% of all patent applications. U.S. 
Patent Statistics Chart Calendar Years 1963 – 2010, < http://www.uspto.gov/web/offices/ac/ido/oeip/taf/us_stat.htm> 
accessed 14 December 2011 
16
 A calculation of patent registrations compared to patent applications per year according to statistics provided by the 
Japan Patent Office. Patents were granted approximately 27% in 2001, 29% in 2004, 34% in 2006, 42% in 2007, 45% 
in 2008, 55% in 2009, and 65% in 2010 
Outline of the Annual Report 2011, Part 5: Statistical Data, Tokyo: Japan Patent Office, 2011 
<http://www.jpo.go.jp/shiryou_e/toushin_e/kenkyukai_e/pdf/annual_report2011/part5.pdf > accessed 14 December 
2011  
17
 S.M. Hankins and D.C. Ohly, Patent Reform 2011: The Most Significant Change in Patent Law in 50 Years, 
Intellectual Property Group Update, Schiff Hardin LLP, 29 September 2011     
18
 S.M. Hankins and D.C. Ohly, op. cit. 
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shown in the steep rise in the graph below. Its grants of patents in 2010 were approximately 30 percent 
higher than those in 2005. From 2007, the USPTO has increased its grants of patents as well. 
 
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
USPTO 53.21151.719 51.09 47.44337.77643.39237.71538.16639.75246.964
JPO 27.72128.50529.65729.35428.78734.59941.62445.25655.46564.624
EPO 21.02128.86535.17832.41626.95929.78324.57626.46824.81524.724
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     (Sources: U.S. Patent and Trademark Office, Japan Patent Office, and European Patent Office)19 
 
Below is a chart demonstrating the number of patent applications and patent grants by one hundred 
and ten national and regional patent offices around the world from 2001 to 2010, as gathered by the 
World Intellectual Property Organization (WIPO). As we see from the chart, the numbers of patent 
applications and patent grants are increasing. On one hand, the trend may reflect more research and 
development by innovators applying for patents. On the other, the increase in the rate of patents granted 
may be a sign that patent quality is suffering. 
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                                            (Source: WIPO Statistics Database)20 
 
Therefore, the registration and examination system for granting patents needs good resources and 
regular improvement to maintain the efficient granting of high quality patents and to increase value in 
excess of what patents cost society.21 Patents must only be granted through effective quality control 
procedures. Most countries have introduced the opposition procedure to control patent quality, allowing 
third parties to object to an application regarding its patentability. Pre-grant opposition can be filed once 
                                                 
19
 European Patent Office, European patents and patent applications - 2010 statistics, < http://www.epo.org/about-
us/statistics.html> accessed 4 January 2012 
20
 WIPO, Statistics on Patent, < http://wipo.int/ipstats/en/statistics/patents/> accessed 4 January 2012 
21
 R.P. Merges, As Many As Six Impossible Patents Before Breakfast: Property Rights for Business Concepts and 
Patent System Reform [1999] 14(2) Berkeley Technology Law Journal 577 at 584 
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applications are published, while post-grant opposition can be filed during a certain period after grant of 
patent. Both systems have their advantages and disadvantages. 
2. Patent opposition system: Pros and Cons 
Pre-grant and post-grant oppositions can overcome the problem of insufficient resources and information 
experienced by patent offices by allowing third parties to share prior art and other relevant information, 
including physical evidence as well as the testimony of experts, to determine novelty at the time of filing 
a patent application.22 Opposition procedures also help to balance the interests of competitors, applicants 
and the public; 23ensure that patents are granted only for well-qualified patentable inventions; reduce un 
patentable applications; and discourages fraudulent and repetitive claims. Questionable patents are 
revoked in case of post-grant opposition. Individuals and small inventors generally benefit from 
restricting the grant of bad quality patents to large enterprises.24 
Additionally, the opposition procedure creates incentive among third parties and the applicant’s 
competitors to make the opposition application accurate and convincing.25 Successful patent opposition 
lessens the burden upon patent offices to examine the validity of patents, has the prospect of greatly 
reducing patent litigation, and can increase social welfare.26 The system can prevent litigation in the first 
place as well as avoid giving rise to innovation-inhibiting licenses in technology in the low quality 
patents. Hence, there seem to be more gains than losses from the use of the opposition system.27 
2.1. Pre-grant Opposition 
Pre-grant opposition is a legal procedure by which third parties oppose a patent application after its 
publication but before the grant of a patent. The inventive step in the application is disclosed to the public 
at the time of publication in a patent gazette as well. A patent office offering a pre-grant opposition must 
manage publication well to reduce the chance that others will make the same or similar inventions before 
the applicant receives a patent. In addition, opposition allows third parties to challenge applications 
regarding patentability. The system ensures that the examiners are aware of essential information required 
for examining patents. Third parties can oppose the application on the basis of any point that examiners 
have overlooked. Countries that use the pre-grant opposition system include India, Brazil, Germany, New 
Zealand and Australia.28 The United States is the latest country to join the pre-grant opposition system 
following the America Invents Act 2011. Below are some costs and benefits of the pre-grant opposition 
system. 
2.1.1. Costs 
Lengthy period 
The typical criticism of the pre-grant opposition is that it prolongs grant of patent. The long wait for the 
grant of Patent can make patentees and their licensees encounter tremendous loss through uncertainty. For 
example, in the pharmaceutical industry, applicants invest remarkable amounts of money to research 
                                                 
22
 R.P. Merges op. cit. p.613  
23
 T. Adam and M. Spence, Opposition in the European Patent Office: An Underestimated Weapon? London & 
Oxford: Olswang/OIPRC, 2001, p.6, <http://www.usyd.edu.au/vice-chancellor/docs/underestimated.pdf> accessed 14 
December 2011  
24
 15 N.B. Zaveri, Effective Mechanisms to Challenge the Validity of Patent (Pre-Grant & Post-Grant Opposition 
Revision of the Presumption of Validity of Patent), Geneva: WIPO, 2006 
<http://www.wipo.int/export/sites/www/meetings/en/2006/scp_of_ge_06/presentations/scp_of_ge_06_zaveri.ppt> 
accessed 14 December 2011 
25
 M.A. Lemley, Rational Ignorance at the Patent Office [2001] 95(4) Northwestern University Law Review 1525 
26
 B.H. Hall, S.J.H. Graham, D. Harhoff, and D.C. Mowery, Prospects for Improving U.S. Patent Quality via Post-
grant Opposition, Working Paper No. W9731, Cambridge, MA: NBER, 2003, p.13 
<http://elsa.berkeley.edu/~bhhall/papers/BHH%20IPE%20May03WP.pdf> accessed 14 December 2011 
27
 B.H. Hall, S.J.H. Graham, D. Harhoff, and D.C. Mowery, op. cit. 
28
 P.C. Gandhi, TRIPS and Development of IP Laws in India: Specific Reference to the Pharmaceutical Sector, 
Conference on Development and Intellectual Property (IP)Sep 01-03, 2008, Geneva: WIPO, Goa 
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chemical combinations for potential drugs but cannot produce the drugs for sale unless they have received 
patents.29 Moreover, patent applicants may become dissatisfied with the system if competitors use it as a 
business strategy to unnecessarily delay grant of patent. 
Disclosure of innovations 
Another disadvantage of the pre-grant opposition is that applicants must disclose the patentable 
technology in innovations in order for the patent office to publish the application for potential third party 
opposition. The disclosure makes applicants’ secrets available to the public and makes infringement 
easier especially given there is no patent granted yet. 
More financial support for patent offices 
Patent office unavoidably requires more financial support because examiners must thoroughly check 
information in the opposition as well as prior art in other patent offices and elsewhere in the world. The 
fee and wages of examiners are also counted.30 
Effects of unsuccessful opposition 
A pre-grant opposition system has the potential to reduce the cost of litigation. However, if the opposition 
is unsuccessful, the dispute may go to court anyway. At the end, the system might be regarded as useless 
and make third parties expend more time and money than had they just brought the case straight to the 
courts.31 
2.1.2 Benefits 
Prevention of grant of bad patents 
Pre-grant opposition can prevent low-quality or questionable patents. Consequently, the economy will not 
be harmed and competition among producers will continue fairly, with the social cost balanced since 
quality patents are being granted. Patentees for quality inventions also deserve to have good protection for 
their hard work as well as to receive proper returns. 
 Prevention of abusive applicants 
The pre-grant opposition protects the abuse of the patent system by considering applications until they are 
spotless and ready to be released for public use. The pre-grant opposition can discourage companies from 
filing applications for patents with slightly different features, such as a different color of the pill bottle for 
patented medicine near expiry, as has happened in the United States.32 
Low cost 
Pre-grant opposition is a cheaper and faster procedure than having litigation in court.33 The cost savings 
are considered to be the strongest point of the pre-grant opposition, allowing third parties the chance to 
invalidate the applications without having to spend a great deal of money and time in court. 
Support for innovators 
Opposition can help individual inventors, smaller sized companies and the public, especially in regard to 
the pharmaceutical industry.34 Since a patent office gives lengthy consideration to patent applications of 
large companies before patents is granted, expensive drugs from these companies will not be marketed 
                                                 
29
 N.B. Zaveri, op.cit. 
30
 R.P. Merges, op.cit., p.610 
31
 M.A. Lemley, op.cit., p.152 
32
 N.B. Zaveri, op.cit. 
33
 P.C. Gandhi, op.cit. 
34
 N.B. Zaveri, op.cit. 
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until the patent is granted, which presents an opportunity to save millions of lives, particularly those of 
the poor who can find alternative drugs at a cheaper price while the patents are in process. A very good 
example is the case of Novartis’ application for a patent for Glivec, which after being under consideration 
for many years was finally rejected by Indian Patent Office, enabling six generic manufacturers to 
continue producing medicine treating blood cancer and thereby relieving patients from the burden of 
high-priced medicines.35 
2.2. Post-grant Opposition 
As mentioned, post-grant opposition is a legal procedure in which third parties oppose the grant of a 
patent within a certain period after it is granted. There are many countries whose patent registration 
systems use the post-grant opposition, including China, South Korea, Brazil, and India.36 The EPO has 
also used the system for a long time. Art. 99 of the European Patent Convention renders that any 
opposition to a patent must be made within nine months from the publication of the grant of patent. The 
US has just adopted the nine-month post-grant opposition proceeding in its reform law.37 The law allows 
any challengers to oppose a patent that should not have been issued in the first place within nine months 
after publication. The US Congress has just issued legislation in the America Invents Act that improves 
the functioning of US patent system, updating it to a first-inventor-to-file system.38 The system allows 
third parties to submit information related to a pending application. A disclosure of prior art will better 
positions the examiners to grant only high quality patents. 39 
However, anyone filing an opposition must be aware of the opposition timeframe. If the opposition 
period is over, filing suit is the only way to cancel a patent, exploiting time and expense of related parties 
unnecessarily, not to mention the adverse effect on the applicant and on society when technology cannot 
be used and protected in due time. The post-grant opposition can maintain the interest of related persons, 
including competitors, even after the grant of a patent. The process, nevertheless, has both costs and 
benefits. Any country that wishes to adopt a post-grant opposition system should conduct due diligence, 
researching established systems and comparing them thoroughly. Below are some costs and benefits of 
the post-grant opposition system. 
2.2.1. Costs 
Undermines the credibility of patent system 
The system of post-grant opposition can be understood as an attempt to correct patents even after the 
grant. This can create uncertainty and confusion in patentees about the system of intellectual property 
                                                 
35
 V. Gill, Novartis loses landmark Indian patent law case, London: Royal Society of Chemistry, 2007 
<http://www.rsc.org/chemistryworld/Issues/2007/September/NovartisLosesLandmarkIndianPatentLawCase.asp> 
accessed 14 December 2011. However, the case is beginning to force India to have pre- and post-grant opposition in 
harmonization with the TRIPS. And S. Chaudhuri, the larger implication of the Novartis-Glivec judgment, Economic 
and Political Weekly, 27 April 2013 <http://www.epw.in/commentary/larger-implications-novartis-glivec-
judgment.html> accessed 27 April 2013 
36
 Park, Chan, “Patent challenges in India and beyond”, Intellectual Property Rights and Vaccines: Promoting R&D 
and Production in Developing Countries, Conference in Tokyo, Japan, 17/11/ 2009 < 
http://www.who.int/vaccine_research/documents/IVR_IPR_Tokyo_Session6_Park_presentation.pdf>accessed 2 
January 2012 
37
 The America Invents Act, Promoting American Innovation, Creating American jobs, growing America Economy, 
< http://leahy.senate.gov/imo/media/doc/PRESS-Summary-OnePager-FINAL.pdf> accessed 14 December 2011 
38
 The America Invents Act, op. cit. 
39
 The America Invents Act or Patent Reform Act 2011 is introduced by Senator Leahy. It adopts the first-to-file 
system for patent application and enhances damages and compensation for patentees. The law is the first major 
overhaul of US patent law in decades. Some view that the law favors big corporation and lessen opportunity for 
individuals and small companies.  
       For more information, see the bill at <http://www.govtrack.us/congress/billtext.xpd?bill=s112-23>;  
       Patent Reform Act of 2011: An Overview < http://www.patentlyo.com/patent/2011/02/patent-reform-act-of-
2011-an-overview.html>; and  
       Lee, Timothy B., Mostly pointless patent reform bill goes to Obama for signature, < http://arstechnica.com/tech-
policy/news/2011/09/mostly-pointless-patent-reform-bill-goes-to-obama-for-signature.ars> 
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rights.40 Also, it can undermine the faith of the public and investors in how patents are issued and in the 
enforceability of property rights granted by patent offices.41 It is also awkward for patent offices to 
correct their decisions about patents that have just been granted. 
Abuse of the system by competitors 
The competitors of patentees can use the post-grant opposition as a means to ruin credibility of the patents 
or to obstruct the patentees. The competitors may oppose without disclosing their identity by the use of 
“straw man” method, 42which abuses the opposition procedure. 
Innovators’ incentive 
No one wants to create innovations with no intellectual property right protection. The patent registration 
system protects innovations from being used, re-produced or sold by the others as well as giving 
innovators incentive to produce more works. However, the post-grant opposition process can discourage 
innovators, since their patents have the possibility of being revoked by the opposition even after they are 
granted. 
More support for patent offices 
From a patent office’s point of view, although opposition is cheaper for third parties than court litigation 
because the whole proceeding is conducted within the patent office with set fees and rules, patent offices 
need more financial support to conduct the whole procedure. Staff and examiners also face a greater 
workload. 
Time limit 
Post-grant oppositions must be filed within set time limits. For example, third parties have nine months 
from the publication date of patent in the EPO and USPTO opposition systems.43 Afterwards, third parties 
have to bring a dispute to court. Post-grant opposition cannot provide assurance that there will be no 
litigation, which may make third parties question whether to pursue litigation instead. Finally, a system 
offering post-grant opposition may lead to more litigation than one without such an option, as if there 
were no post-grant opposition proceeding at all, third parties could use the pre-grant opposition 
proceeding or go to court directly. They would not have to litigate against the grant of patent or appeal the 
decision of the opposition board. 
2.2.2. Benefits 
Improvement of patent quality 
Post-grant opposition can improve patent quality by reducing litigation costs and by ensuring only high 
quality patents are granted, thereby protecting the public interest and strengthening competition and the 
economy, with only quality patented products entering the market.   
Friendly atmosphere 
If an opposition fails, many systems allow third parties to proceed to the revocation process. Third parties 
may save some expense from defending themselves in patent infringement lawsuits since the opposition 
process is cheaper than litigation in court. The opposition atmosphere is also less strained than revocation. 
                                                 
40
 AMPICTA, Post-Grant Patent Enforcement Strategies, Canberra: AMPICTA, 2006, 
<http://www.acip.gov.au/enforcesubs/AMPICTA%20-Brian%20Jones.pdf> accessed 15 December 2011 
41
 J.P. Kesan, Carrots and Sticks to Create a Better Patent System [2002] 17(2) Berkeley Technology Law Journal 
763 
42
 M. Spence, op.cit., p.19 
Straw man method is referred to someone providing anonymity to any company for opposing a patent. 
43
 Art. 99(1) of the European Patent Convention < http://www.epo.org/law-practice/legal-
texts/html/epc/2010/e/ar99.html > accessed 15 December 2011 
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Patentees will not lose face at the opposition stage because the patents have only just been granted and 
have not yet been marketed widely.44 
Benefit to individual inventers and small companies 
Post-grant opposition can delay the granting of a patent. Normally large companies that have sufficient 
research and technology resources and funds have a better chance to receive a patent for their innovations 
than individual inventers and small companies who lack of these resources and funds. The delay of patent 
gives them a chance to develop their innovations and receive a patent of their own during the prolonged 
opposition period. 
As described, there are both costs and benefits for each patent opposition system. One system may 
suit a particular country while another may not. Thailand as a developing country in South East Asia has 
chosen to use the system of pre-grant opposition for its patent registration for some time. The forty-year 
plus history of the pre-grant opposition system in Thailand surely offers something about its efficiency 
and reliability for Thailand. Also, it may provide insight for other developing countries whose innovation 
and development of technology are still behind developed countries even as their patent law faces 
pressure to align with the standards of developed countries. In the following section, the author presents a 
thorough overview of the patent system in Thailand before analyzing key decisions of the Board of 
Patents. 
3. Patents in Thailand 
Thailand enacted its current patent law almost four decades ago. Over time, the Thai patent system has 
improved gradually. Anyone wishing to have a protection for his invention or its process or a design must 
register for patent at a patent office in the Department of Intellectual Property, Ministry of Commerce. 
While the patent registration procedure in Thailand has its unique features, it also complies with 
minimum standards set by relevant international treaties. There are three categories of patent registration 
in Thailand: invention/process patent, design patent, and petty patent. Each type of patent has different 
requirements, procedures and protections. Thailand, like many countries, also has a pre-grant opposition 
system, as discussed above. The pre-grant opposition system allows any interested person to be able to 
oppose a registration of a patent within 90 days after a publication date of a patent application. If an 
opposition is rejected by the Director-General of the Department of Intellectual Property, an appeal to the 
Board of Patents can be made. However, if the Board of Patents rejects the appeal, interested persons are 
still eligible to appeal the decision of the Board of Patents to the Central Intellectual Property and 
International Trade Court within 60 days after an announcement of the Board’s decision. Even better, if 
the Court rejects the appeal, the Intellectual Property and International Trade division of the Thai 
Supreme Court serves as further recourse. Finally, if these measures fail and the patent office grants a 
patent to an applicant, the revocation process may invalidate the patent. 
From this point of view, it is not wrong to say that Thailand has a good systematic patent law and 
strong patent opposition system. Thai patent system is worthy of study as an example of a patent 
opposition system that can improve patent quality domestically. 
3.1. History of Patents in Thailand 
The Kingdom of Thailand is a developing country in South East Asia. In the past, the country had never 
had a patent law or any public order similar to said law. The Siamese or Thai people were concerned 
more about living by agriculture and livestock. A century ago, there was an attempt to issue a law after 
the “Law on Patents” of England in the era of King Rama XI.45 Nevertheless, the first attempt failed. 
Several attempts to enact a patent law followed, but all attempts were rejected or forgotten due to the 
World War II and insufficient expertise in patent law. Moreover, a belief that a patent law would benefit 
foreigners more than the Thais or that the law would restrict Thais from accessing innovations and 
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technology also discouraged furtherance of legislation.46 However, the attempt to enact a patent law 
succeeded in 1979 when the Parliament passed the Patent Act, drafted by the Ministry of Commerce as 
the Patent Act B.E. 2522 (1979). The draft was written following the Paris Convention, allowing 
foreigners to have national treatment.47For example, a foreign application could be filed in Thailand 
twelve months after the first applications in other countries and still be regarded as novel. Albeit Thailand 
was not yet a party of the Convention at that time, the Patent Act set same standard for people of other 
nations of the Convention with the people of Thailand. Debate followed as to whether the Patent Act was 
beneficial for the country. . 
In 1992, Thai Patent Act B.E. 2522 was amended for the first time as a sequence of pressures by 
developed countries especially from the U.S. The U.S. wanted Thailand to raise the standard of patent 
protection for American pharmaceutical companies. If Thailand did not amend the Patent Act, the U.S. 
indicated it would obstruct all commercial activities with Thailand.48 Therefore, some provisions were 
removed while some provisions were changed to suit developed countries. For example, pharmaceutical 
companies could register their drugs for patents after the amendment, and a period of patent protection 
was increased to twenty years from fifteen years.49The opposition procedure was introduced for the first 
time in this amendment as well.  
Thai Patent Act was amended again in 1999 to be in accordance with the Agreement on Trade Related 
Aspects of Intellectual Property Rights (TRIPS). Since TRIPS set minimum standards in 1994 for many 
of the intellectual property regulations of World Trade Organization members, Thailand as one of the 
members was obliged to apply these provisions.  Generally, the third version of the Patent Act induces 
incentive of patentee incredibly. For example, provisions for petty patent were added in Chapter III bis – 
Petty Patent while provisions for pharmaceutical patent in Part VII – Measure for Pharmaceutical Patent 
were removed.50The Department of Intellectual Property introduced a draft for the third amendment in 
2006 but ratification has languished given controversy over a number of items, including a provision 
about removing the pre-grant opposition system and introducing a six-month revocation system. The 
argument continues as of the drafting of this article.    
3.2. Overview of Patent Registration in Thailand 
The patent registration system in Thailand came into being after its trademark registration system. During 
the reign of King Rama VI, the Trademark Registration Unit was established in 1910 under the Ministry 
of Agriculture to protect Thailand’s trademarks and trade names in global commercial activity.51 Thirteen 
years later, the King compelled the House of Lords to issue a royal command to establish the Department 
of Commercial Registration. The Department formed the Patent Investigation Division to hold 
responsibilities on patents in 1963 during the reign of King Rama IX, the current king.52 The patent 
registration system was fully established in 1979 when the Patent Act of Thailand was enacted. Rules and 
regulations including fees for patent registrations were announced as a consequence. 
As mentioned above, the Patent Act was amended twice following international treaties and forces of 
developed countries. The amendments made the Act and registration system accord with the patent 
section in TRIPs.53 Therefore, the patent registration system in Thailand is similar to those of the other 
TRIPs member countries. However, differences can arise from undefined provisions in TRIPs. For 
example, the patent opposition system in member countries may vary since there is no opposition 
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provision mandated in TRIPs. While Brazil and Australia use a pre-grant opposition system, South Korea 
and the US have chosen post-grant opposition.  
In the Thai patent registration system, there are three types of patent registration: invention, design 
and petty patent. Each type represents varied protections and requires different qualifications. Inventions 
that can apply for an invention patent must be novel, have an inventive step and be industrial applicable.54 
An invention patent has a twenty-year protection from the date of filing an application in the country.55A 
design patent protects an industrial design for ten years from the date of filing application in Thailand.56A 
registered design patent must be new and applied for industry and handicrafts.57A petty patent requires 
that an invention must be new and industrially applicable, 58and is protected for 6 years from the date of 
filing the application in the country.59 
Anyone who wishes to apply for patent registration must choose a type of patent that suits his 
invention or design. The basic factors used to consider are (1) if the subject matter is created mainly for 
usage without or with minor aesthetic value, the applicant should apply for an invention patent or petty 
patent for the subject matter; but (2) if the subject matter is created to appeal as decoration with aesthetic 
value taking priority over usage, applicants should seek a design patent.60 Therefore, to choose whether an 
invention is suitable for invention patent or petty patent one must look at the complexity of the invention. 
If the invention has a complicated technique and can be industrially reproduced, the invention is suitable 
to be registered as an invention patent.61Nonetheless, a petty patent applicant may switch to an invention 
patent if the patent has not yet been granted, as might be desirous for an application anticipated to be 
rejected for lacking an inventive step. In the same way, an applicant for a petty patent may instead file for 
an invention patent if it is determined that the invention meets the criteria. This can happen any time 
before the registration of the invention or before the publication of the application under Section 28, as 
the case maybe.62However, there is no provision for a design patent application to change to an invention 
or petty patent application even when the design functions as an invention.63 The design patent 
application must be withdrawn in order to file a new invention or petty patent application.64 
3.2.1. Registration of invention patent 
As for invention patent registration in Thailand, in short, an application must include a patent application 
form, filing fee, description of the invention, claims, abstract, drawing and any other documents as 
available.65After filing the application, if the officer finds minor errors in the application, he will notify 
the applicant or an agent of the applicant to correct those errors. The correction shall be done within 90 
days from the date of notification. If the applicant needs more time, he shall appeal for the extension. If 
there is no error in the application or the error is already corrected, the officer will notify the applicant 
twice to pay a fee for publication within 60 days from the notification date. Failing to pay a fee will be 
deemed as abandonment of the application. If the publication fee is paid in a due time, the publication of 
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the application will be published for 90 days for opposition by any interested person under conditions: (1) 
the application does not comply with the patent law; or (2) the invention belongs to opposing party.66 
If the publicized application is not opposed during the 90 days after publication, the applicant must 
proceed to the examination process. The request for an examination must be submitted within 5 years of 
the date of publication together with the examination fee. But if the application is opposed, a competent 
officer will consider the opposition and counterstatement by the applicant to determine whether the 
invention belongs to the applicant or not. Subsequently, the officer will report on his decision to the 
Director-General and send the decision to both the applicant and opposing party. The decision must either 
reject the opposition or nullify the application. If the officer decides to reject the opposition, the applicant 
proceeds to the examination process, in which the subject matter is compared to prior art and assessed for 
its qualifications as specified by the law. A qualified application will be granted a patent after paying the 
registration fee; an application that does not meet the qualifications will be nullified. 
 
Flow Chart of Examination Process for an Invention Patent Application 
 
(Source: Department of Intellectual Property)67 
3.2.2. Design patent registration 
The design patent procedure is a bit different from that of an invention patent. The design patent 
opposition system adopts opposition provisions from the invention patent to ensure that the granted 
design patent has all qualities required by the law. Once submitted, a design patent application will have a 
preliminary examination for minor errors. If there are any errors, the applicant will be notified to correct 
them. Correction shall be done within 90 days after the date of notification. If the application does not 
have any error or the errors have already been corrected, the applicant must pay the fee for publication of 
the application. The officer will notify the applicant twice of the need to pay for publication fee within 60 
days from the notification date. Failing to pay a fee will be deemed as abandonment of the application. 
                                                 
66The Department of Intellectual Property, Patent Registration Process, < 
http://www.ipthailand.go.th/ipthailand/index.php?option=com_content&task=view&id=168&Itemid=205&lang=en> 
accessed 12 June 2012 
67The Department of Intellectual Property, Flowchart featuring for a patent for invention application, < 
http://www.ipthailand.go.th/ipthailand/index.php?option=com_content&task=view&id=1076&Itemid=205> accessed 
16 June 2012 
  
 
   
  
Improving Patent Quality through Pre-grant Opposition in Thailand  
  
 
231 
 
Interested persons have 90-day period to oppose the application under the following conditions: (1) the 
application does not comply with the patent law; or (2) the invention belongs to an opposing party.68 
Qualified application will be granted a design patent; while, disqualified application will be nullified. 
Flow Chart of Examination Process for a Product Design Patent Application 
 
(Source: Department of Intellectual Property)69 
3.2.3. Petty patent registration 
Finally, petty patent registration mirrors the aforesaid patent procedure until the error notification process. 
If a petty patent application does not have any errors or an applicant has already corrected those errors, 
the applicant will be notified to pay a registration fee. There is no opposition or examination process 
before the grant of petty patent. But after the grant of a petty patent, any interested person can submit a 
form requesting the patent be examined as to whether it complies with the law. If examiners find that the 
petty patent is noncompliant, the petty patent will be nullified.70 
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Flow Chart of Examination Process for a Petty Patent Application 
 
(Source: Department of Intellectual Property)71 
3.3. The System of Pre-grant Opposition in Thailand 
As mentioned above, of Thailand’s patent opposition process system only serves invention and design 
patents. Petty patents do not have an opposition process but an interested person may request the 
competent office to examine the invention as to whether it has all requirements according to Section 65bis 
after the grant of a petty patent.72 Thailand’s Patent Act B.E. 2522 provides for invention patent 
opposition procedures from Section 31 to Section 34. Design patent opposition can use the same 
provisions mutatis mutandis as mandated in Section 65 of the same Act.  
Opposition procedures begin with Section 28 of the Patent Act, which states that opposition of a 
patent application can be undertaken within 90 days after a publication date of an application. The 
Department of Intellectual Property publishes a gazette listing new patent applications every month. 
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Patent applications are also published online on the Department of Intellectual Property’s website.73After 
consulting either source, anyone wishing to oppose a patent application may notify the competent officer 
for opposition upon the ground that he is entitled to the patent or that the application does not comply 
with the provisions of Section 5, 9, 10, 11 or 14.74 Section 5 refers to subject matter in a patent 
application lacking in novelty, inventive step, or industrial applicability. Section 9 refers to a subject 
matter of patent application not patentable as listed in the Section. Section 10 refers to an inventor that 
has no legitimate rights to apply for a patent. Section 11 refers to an invention that an employee creates 
under an employment contract. Finally, Section 14 refers to an applicant who does not qualify as having a 
connection with Thailand. If an opposing party wishes to submit other evidence in support of his 
opposition, it has to submit such evidence within 30 days of the date of submission of the opposition. 
Otherwise, no further opposition can be submitted at the first stage until appeal. The opposing party has to 
pay a fee of 250 baht (THB) (approximately 9 USD) and submit the opposition within 90 days from a 
publication date of the application as well. Further supportive evidence of the opposition (if any) must be 
submitted together with a fee of 50 THB (around 2 USD) within 30 days from the date of filing the 
opposition.  
Once the submittal period has ended, the officer will send a copy of the notice to the applicant, who 
then has 90 days from the date of receipt of the copy to file a counterstatement in response to the copy of 
the notice. The applicant may file any supportive evidence further from the counterstatement within 30 
days from the date of submission of the counterstatement together with a fee of 50 THB (around 2 USD). 
If the applicant fails to file such counterstatement within the period of 90 days or 30 days (for further 
evidence, if any), he will be deemed as having abandoned his application.75The competent officer must 
notify both the applicant and the opposing party to the abandon of the application. 
The aforesaid evidence in supporting of the opposition and counterstatement are buttressing evidence. 
The opposing party and the applicant can also introduce any evidence or file any additional statement in 
order to support their opposition and counterstatement in accordance with the procedures prescribed by 
the Director-General. As directed by Section 32, when the Director-General has made a decision under 
Section 33 or Section 34, receipt of the decision with given reasons will be sent to the opposing party and 
the applicant.76 
If an applicant makes a request for examination within 1 year from the publication date and there is an 
opposition77in a case where the officer’s examination has determined that the application and invention 
abide by the law and regulations of the Patent Act78, the officer has to submit his examination report to 
the Director-General of the Department of Intellectual Property. Once the opposition and 
counterstatement are filed, the Director-General will consider whether the invention belongs to the 
applicant or the opposing party. If the Director-General decides that the invention is to be registered and 
granted to the applicant, he will order so and reject the opposition, provided that there is no appeal from 
an opposing party, the patent officer then has to notify the applicant to pay the fee within 60 days from 
the receipt of such notice. When the fee is paid, the invention will be registered and a patent will be 
granted to the applicant within fifteen days after the payment of the fee, but not before the expiration of 
period of appeal prescribed in Section 72. If the fee is not paid within the aforesaid period, the application 
will be deemed as abandoned. The patent must be in the form prescribed by the Ministerial Regulations.79 
Opposing parties must appeal within 60 days after the date of notification of decision by the Director-
General. If there is an appeal of the decision to the Board of Patents or the Court, the party must wait for a 
decision of the appeal from the Board or the Court. However, if the Director-General decides that the 
invention belongs to the opposing party, the Director-General will reject the application. If there is no 
appeal of the decision by the applicant or the Board, or the Court has made a final decision regarding the 
appeal, where the opposing party has filed an application for a patent within 180 days after the rejection 
of the application by the Director-General or from the date on which the final decision is made, as the 
                                                 
73
 The Department of Intellectual Property, Patent Publication, Available at 
<http://www.ipthailand.go.th/ipthailand/index.php?option=com_wrapper&Itemid=605>  (The publication is in Thai 
only) 
74
 Section 31 of the Patent Act B.E. 2522 (1979)  
75
 Section 31 of the Patent Act B.E. 2522 (1979) 
76
 Section 32 of the Patent Act B.E. 2522 (1979) 
77
 Section 29 of the Patent Act B.E. 2522 (1979) 
78
 Section 24 of the Patent Act B.E. 2522 (1979) 
79
 Section 33 of the Patent Act B.E. 2522 (1979) 
  
 
   
  
W.  Puasiri 
   
 
234 
 
case may be, the opposing party will be deemed as filing its application on the filing date of the applicant, 
and the publication of the application of the applicant made under Section 28 will be deemed as the 
publication of the application of the opposing party. In the latter case, no person may oppose the 
application of the opposing party on the ground that such person has a better right in the invention than 
the opposing party.80 
 
Flowchart of the Thai Patent Act Opposition Process 
 
 
3.4. Patent System Enforcement Mechanism in Thailand 
Section 36 of the Patent Act mandates that a patentee, when the subject matter of a patent is an invention, 
has exclusive rights to produce, use, sell, have in the possession for sale, offer for sale or import the 
patented product. However, if the subject of a patent is a process, the patentee has the right to use the 
patented process, to produce, use, sell, have in the possession for sale, offer for sale or import the product 
produced by the patented process. Accordingly, a patentee of a design patent also has an exclusive right to 
manufacture a product or to sell, have in possession for sale, offer for sale or import a product, 
embodying the patented design, except the use of the design is for the purpose of study or research 
according to Section 63 of the Patent Act. 
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If anyone who does not have permission from a patentee performs actions that a patentee has an 
exclusive right in, that person commits an infringement of a patent. Thailand has provisions for patent 
infringements in Chapter VI of the Patent Act B.E. 2522. Penalties for offenses include fines and 
imprisonment. Section 85 reads  
“Any person who commits any act under Section 36 or 63 without the permission of the 
patentee shall be punished with imprisonment not exceeding two years or a fine not 
exceeding four hundred thousand baht or both.”81 
 
To enforce the law, a patentee or any interested person can file a lawsuit with the Central Intellectual 
Property and International Trade Court (the Court) within a prescribed time limit.82 There are 5 types of 
lawsuits regarding patents.83The first covers violation of patent in a civil case to claim for compensation. 
The second regards revocation of a patent. The third involves cancellation of a decision or order of the 
Board of Patents. The fourth involves executive orders of the Prime Minister in relation to patents during 
a state of war or emergency.84 The fifth covers cases where many persons have invented the same 
invention individually according to Section 16.  
In case of patent opposition, if any party does not agree with a decision of the Board of Patents, that 
party has a right to appeal the decision of the Board of Patents to the Court within 60 days from the date 
of receipt the decision of the Board. If there is no appeal to the Court within 60 days, the Board of 
Patents’ decision is final. However, if there is an appeal to the Court within 60 days but the Court also 
decides in agreement with the Board of Patents, the party can appeal the judgment straight away to the 
Intellectual Property and International Trade Division of the Supreme Court within 1 month from the date 
of publication of the judgment. The party does not have to bring the case to the Court of Appeal before 
passing the case to the Supreme Court because Thailand regards intellectual property and international 
trade cases as special cases requiring a speedy and convenient process.85 When the Supreme Court makes 
a judgment, the judgment is final. Further details about the appeal procedure to the Supreme Court are as 
follows: in criminal cases in which penalties involve no more than 3 years imprisonment or a fine not 
exceeding 60,000 THB, the party is forbidden to appeal in factual questions, except where the judgment 
has already ordered imprisonment or a 5,000 THB fine. In civil cases, if the price of property or disputed 
asset is below 200,000 THB, the party is forbidden to appeal in factual questions, except where is a 
dissent opinion or certified letter from a trial judge or the chief judge of the Court allows the appeal in 
writing. 
Nevertheless, the opposition via the Patent Office is not the last means to obstruct patent registration. 
Even after patent registration, there is also a procedure to cancel the patent by the Court. For invention 
patents, Section 54 of the Thai Patent Act provides that  
Any patent granted not in compliance with the provisions of Section 5, 9, 10, 11 or 
Section 14 shall be invalid. 
The invalidity of a patent may be challenged by any person. A petition to cancel an 
invalid patent may be submitted to the Court by any interested person or the public 
prosecutor.”86 
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Therefore, any patent if not granted in compliance with the provisions of Section 5, 9, 10, 11 or 
Section 14 will be invalid. Any person can challenge the Director-General about an invalid patent. Then 
the Director-General can request the Board of Patents to cancel the patent. Otherwise, any interested 
person or the public prosecutor can submit a petition to the Court to cancel an invalid patent. In case the 
Court disagrees with such person or the public prosecutor, the party still can appeal a judgment to the 
Supreme Court. Moreover, the Director-General can request the Board to cancel a patent in particular 
circumstances as prescribed in Section 55 of the Patent Act. The invalid patent refers to a patent that is (1) 
a non-patentable invention,87 (2) an invention which cannot have a protection under the law,88 (3) a patent 
whose patentee is not the inventor who has a right to apply for the patent,89 (4) a patent whose patentee 
does not have a right to apply for the patent due to an employment contract,90 or (5) a patent submitted by 
an applicant whose qualifications do not agree with the prescribed conditions of a patent applicant, such 
as not having a Thai nationality.91 However, an interested person includes anyone who would be affected 
or damaged by the grant of such patent.92 
For a design patent, Section 64 of the Patent Act allows adoption of cancellation provisions in Section 
54 such that any interested persons or the public prosecutor can file a petition to cancel a design patent to 
the Court if the design is not new and not eligible to register as a design patent as prescribed in Section 
58. Section 58 sets rules that a design conflicting with public moral or a design mandated in Royal Decree 
cannot be a design patent. Moreover, Section 64 also adopts provision of Section 10, 11, and 14 involving 
subject matter unregistrable as an invention patent. In short, a design patent is unable to be registered if 
(1) a patentee is not a creator of a design who has a right to apply for the patent per Section 10, (2) a 
patentee does not have a right to apply for the patent due to an employment contract per Section 11, or (3) 
an applicant’s qualification does not abide by Section 14; for instance, an applicant does not have Thai 
nationality.93 
The Central Intellectual Property and International Trade Court 
The Central Intellectual Property and International Trade Court specializes in intellectual property and 
international trade disputes. Established in 1996, the Court deals with Intellectual Property and 
International Trade related cases only. Its judges and officers are more familiar with Intellectual Property 
than other courts, leading to more accurate decisions. Its specialized judges use their ultimate discretion to 
consider patent and other intellectual property disputes. Therefore, the Court has become a last hope for 
applicants and opposing parties in registering or canceling a patent. The Court is located in Bangkok but 
has jurisdiction over the entire country for cases related to intellectual Property. Nevertheless, if an 
interested person cannot travel to the Court in Bangkok to file a case, any court in Thailand can accept 
patent oppositions under Section 54 of the Act.  Of course, only cases truly deemed to involve intellectual 
property are forward to the IP&IT Court.94 
4. Analysis of Key Patent Oppositions in Thailand  
The opposition system plays an important role in restricting bad or poor quality patents in Thailand 
although, somehow, it has not been of much help in the case of pharmaceutical patents. Nevertheless, pre-
grant opposition is better than post-grant opposition and revocation because pre-grant opposition allows 
the patent office to shield itself from cancellation of a patent and even to control patent quality before any 
patent is issued. Thailand is one of the countries employing a pre-grant opposition system with a period of 
90 days after a publication of an application. The pre-grant opposition system has obstructed bad patents 
in Thailand, which is beneficial to consumers and inventors. The opposition system is very essential for 
consumers; if poor quality drugs can be patented and sold for high prices, many patients will not be able 
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to access the drugs, which is unfair to both consumers and drug inventors. In a relevant case, the Board of 
Patents rejected an appeal from a patent applicant from the appeal of opposition in Decision No. 1/2554, 
resulting in broader access to a generic medicine by the public. The Board ruled Novartis AG’s invention 
patent involving integration of an organic compound in an enhancing flow of insulin drug was similar to a 
U.S. patent and the integration of organic compound did not show any distinctive improvement in terms 
of efficient treatment of disease. Therefore, the appeal to the Director-General was dismissed and the 
application was nullified.95 
Below we explore examples of both failed and successful opposition cases to assess the efficiency of 
the pre-grant patent opposition in Thailand. The Legal Office of the Department of Intellectual Property 
has kindly distributed the examples, which include oppositions of a wide range of patents from 1994 to 
2011. 
4.1. Failed Oppositions  
4.1.1. Initial decisions involving failed patent opposition 
The first failed pre-grant patent opposition was recorded in 1996. It was a case of a design patent 
application for a chair. In the Board of Patents’ decision 10/2540, 96the Director-General of Department 
of Intellectual Property concluded that an application for a design patent was different from the one 
described in the opposition because the latter had already published in magazine “LAYOUT” in Italy 
since 1975. The opposing party appealed, but the Board of Patents upheld the decision of the Director. As 
a result, the opposition was rejected.  
The next failed opposition case was Decision No. 2/2541,97 involving an invention patent application 
by an employee of the National Science and Technology Development Agency (NSTDA). In the 
decision, the applicant applied for an invention patent for a silicon-oxide generator from rice-husk but the 
NSTDA opposed the application with the ground that the applicant had no right to apply for the invention 
due to his employment contract with NSTDA. The applicant filed a counterstatement that the invention 
was not invented under an employment contract and the invention was different from what the applicant 
had to do under the employment contract. The Board of Patents agreed that the silicon-oxide generator 
inventions belonging to the inventor and to NSDA were different in substantive parts. As such, the Board 
rejected the opposition. The NSTDA appealed the decision but the Board of Patents upheld its decision, 
reasoning that the applicant applied for an invention that was dissimilar to the invention in which NSTDA 
had a right. Therefore, the appeal of the opposition was also rejected.  
In Decision No. 1/254898regarding a fire-extinguishing ball invention, an opposing party claimed that 
the application did not have an inventive step and that it had a better right than the applicant. In 2003, an 
applicant had applied for a patent for a fire-extinguishing ball, a ball containing chemical substances that 
can extinguish fire. The ball was designed to use conveniently, self-activating with three seconds once in 
contact with fire. The Board of Patents did not agree with the opposing party’s arguments and rejected the 
opposition. Although the opposing party appealed the decision, the Board of Patents did not agree with 
the appeal and upheld the Director’s decision. 
From the examples of the decisions above, many cons of pre-grant opposition can be found. Pre-grant 
opposition may serve as a method to prolong the grant of patent and exploit time unnecessarily. For 
example, the opposing party in the extinguish-a-fire ball decision merely prolonged the grant of patent by 
filing an unreasonable opposition and appeal. As well, the in the NSTDA decision, if NSTDA would have 
controlled its employee and any research and development resulting from the work created under 
employment, the Patent Office, the Board of Patents and the applicant would not have to waste their time 
considering the opposition.  
Also, considering similarity is very subjective. Once an opposition is made, the Director-General and 
the Board of Patents may view similarities of an invention in an application and an invention raised by an 
opposing party as different or alike subject to attitude, experience and specialization of the individual 
examiner. Therefore, improving patent quality requires not only the opposition procedure but also that 
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officers and examiners of the patent office including the Director-General of Department of Intellectual 
Property and the Board of Patents should also be efficient and able to consider a decision with reasonable 
discretion.  
4.1.2. Unusual Decisions  
The next decision under consideration is No. 2/2548.99 An applicant sought a patent for an instant cement 
mixture, but Kittipong Mining Co. Ltd. opposed the application based on similarity of mixture ingredients 
to prior art. The Director-General considered the application, opposition, counterstatement and all 
evidence. He concluded that the applied invention had a different mixed cement percentage from the 
opposing one. As a consequence, the applied invention was new and had an inventive step, resulting in 
the rejection of the opposition.100 This case was a bit awkward because the Director-General rejected the 
opposition but the opposing party did not appeal. However, when the application proceeded to a 
substantive examination process, the Director-General rejected the application, reasoning that the 
application was similar to US patents. The applicant appealed to the Board and the Board reversed the 
decision of the Director-General. Thus, pre-grant opposition is not always the last chance to correct patent 
quality. It is essential that staff and officers at the patent office must do their best to examine, consider 
documents and have good discretion in order to control the quality of patents. 
4.1.3. Rejection of Oppositions and Appeals by the Director-General and the Board of 
Patents 
There are many decisions where the Director-General has rejected the opposition and the Board of Patents 
has upheld a decision of the Director-General. The author thinks that main reason for failed oppositions is 
because they are not efficient enough. For instance, in Decision No.1/2549101, the Director-General 
rejected the opposition and the Board of Patents also upheld the decision of the Director-General simply 
because a method used to preserve rice by the applicant was new and had an inventive step. This decision 
also showed that the failure of the opposition came from insufficient reasons used to oppose the 
application. Yet, Decision No. 21/2549102 demonstrated an absurd ground for rejection. The Director-
General rejected the opposition because the opposing party did not oppose within 90 days from the date 
of publication of the application. But later on, the Board found in the appeal of the opposing party that the 
opposition was in fact filed within 90 days from the publication date. It is shameful that the Director and 
the Patent Office could not assess the dates correctly. In Decision No. 20/2549103, the opposition failed 
because the opposing party did not raise the expiration of patent application to the Director-General. 
Moreover, the opposing party could not convince the Director and the Board that the differences between 
the stamp design of the applicant and that of the opposing party were only minor changes that did not 
make the design in the application novel. This rejection of an opposition and its appeal demonstrates 
errors of the opposition and opposing party as well, in particular regarding correcting dating. 
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4.1.4. Series of Oppositions 
Another form of failed oppositions is a series of oppositions by one natural or legal person. Questions 
exist as to why an opposing party will claim that many patent applications are similar or identical to his 
patent or are otherwise invalid. In Decision No. 22/2549, Mr. Gonsab opposed a patent application for a 
flying boat claiming that the flying boat was similar to an invention in his patent application. However, 
the opposition was rejected because of the dissimilarity between two inventions.104 Mr. Gonsab opposed 
several other patent applications with varied results. As Decision No. 12/2550 from 2007 reveals, 105 Mr. 
Bhuripongchai opposed a television and radio aerial patent application, claiming that the aerial in the 
application was similar to prior art. His opposition and appeal were rejected because the Director-General 
and the Board of Patents agreed otherwise. Nevertheless, Mr. Bhuripongchai opposed an application for 
television and radio aerial again against the same applicant in Decision No. 13/2550106, yet, the result was 
still rejection because his oppositions were groundless and nonsensical. 
Similarly, in 2008, as detailed in Decision No. 10/2551, 107D.T.C. Industry Public Co. Ltd. (D.T.C.) 
opposed Mr. Suthipong’s design patent application for a pen by claiming that the applicant copied its 
patents and patent application in Indonesia. The Director-General and the Board of Patents rejected both 
the opposition and its appeal because the design of the pen in the application and the claimed patents were 
dissimilar. The same results occurred in a Decision No.16/2551 and 17/2551. In Decision No. 16/2551108 
and 17/2551109, D.T.C. again opposed an invention patent application, in this case for “fluorescent ink for 
the stationary based on the dispersion of pigment agent in non-aqueous solvent” of Bic Corporation of 
America. Similar to the prior decision, the Director-General and the Board rejected both oppositions and 
appeals, reasoning that the invention in the application and the claimed fluorescent ink of the opposing 
party were sufficiently different and that the solvent of the invention in the application had an inventive 
step distinct from prior arts. D.T.C. opposed Bic Corp.’s patent application again in a decision No. 
18/2551110. The decision rendered same results as decisions No. 10/2551, 16/2551, and 17/2551 that was 
both the Director-General and the Board of Patents rejected both the opposition and its appeal. In this 
decision, Bic Corp. applied an invention patent for “non-fluorescent ink for the stationary based on the 
dispersion of pigment agent in no- aqueous solvent” but D.T.C. claimed that the applied invention had 
already existed before the application, which made the invention not novel at the application date. Bic in 
its counterstatement argued that its invention had an inventive step that was an advance over a general 
non-fluorescent and non-aqueous composition. The Director-General agreed with the counterstatement, as 
did the Board of Patents in the appeal stage. As a result, the application continued to the examination 
process. 
This was not enough for D.T.C. In Decision No. 11/2551,111 D.T.C. opposed a design patent 
application by B.K.L. Group Co. Ltd. (B.K.L.) for a pen, alleging that the designs of the pen in the 
application and its patents were very similar. However, although the Director-General rejected the 
opposition, D.T.C. succeeded in stopping the application in its appeal. The Board stated as its main reason 
for rejecting the appeal that the designs of the pens in the application and in D.T.C.’s January 1999 
catalogue were closely similar, which meant that the application was similar to prior arts to the degree 
that one could see the applicant had imitated D.T.C.’s designs. Likewise, Decision No. 12/2551112 
rendered the same results. In the decision, D.T.C. opposed the design patent application for pen of B.K.L. 
The Director-General again rejected both oppositions based on dissimilarity between two designs, but the 
Board of Patents reversed the decision of the Director-General according to grounds similar to Decision 
No. 11/2551.  
In our analysis, D.T.C. as a sizable manufacturer of a variety of pens, is displaying the traits of other 
large and powerful companies in the Thai market who seek to prevent others from registering both patents 
and trademarks which resemble their own products to protect their market share and lessen the 
opportunity for consumers to change brands. Moreover, it should be noted that a few companies dominate 
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the pen market in Thailand. In any case, D.T.C. has had its own patent application opposed by others as 
well. In Decision No. 15/2554,113 D.T.C. applied for a patent for a pen design. Nonetheless, a Mr. 
Suputipong opposed the application, reasoning that the design of the applicant was similar to a disclosed 
design of a pen evidenced in the catalogue year 2000 of Hang Zhou Oversea Pen Co. Ltd. (Hang Zhou). 
The Director-General agreed with the opposition and rejected the application. D.T.C. appealed to the 
Board of Patents. The Board considered every detail of both designs thoroughly and found that the design 
of D.T.C. was sufficiently different from the design of Hang Zhou. D.T.C. was then able to proceed to the 
examination process. Although D.T.C. won against the opposition in the Board of Patents round, it is hard 
to refrain from the thought that the market dominance position of D.T.C. might have influenced the 
decision of the Board of Patents.114 
4.1.5. Pharmaceutical oppositions 
Another type of opposition is a patent opposition in the interest of societal wellbeing by a government 
sector or a non-governmental organization (NGO). Mostly, this type of opposition involves patents for 
medicine that affect public health and benefits broadly. So, if an opposition fails, social benefit will be 
undermined. For example, in Decision No. 17/2550, Besham Pharmaceutical (PTE) Ltd., a Singapore 
pharmaceutical company, applied for an invention patent for a medicine that used a new method to treat 
infection. The Government Pharmaceutical Organization (GPO) opposed the application based on the 
grounds that the applied formula for Amoxicillin and Potassium Clavulanate was already disclosed in 
European patents and that the mixture as layer tablet was common and showed no inventive step. Besham 
filed a counterstatement that the application differed from the European patents because its drug would 
slowly release Potassium Clavulanate in the first phase and release Amoxicillin combined with excipients 
in the second phase. The Director-General found that the drug in fact released active compounds in a 
different rate with those in the European patents and the drug also used a control agent in order to release 
both Amoxicillin and excipients, a procedure not mentioned in the European patents. Therefore, the 
Director-General decided that the invention of the drug was new and unlike those in the patents. GPO 
appealed on the grounds of public interest, stating that if the applicant were granted the patent, people 
would find it difficult to access to similar medicine, which would definitely affect the health of the public. 
Moreover, the European patents had already claimed the released rate of the compound. As such, the 
application should not be allowed. However, the Board of Patents upheld the decision of the Director 
because the Board agreed that the invention of the drug was new and unlike those in the European 
patents, as it had an inventive step developing from the European patents.  
Similarly, in 1997, the GPO opposed a patent application for a therapeutic combination of Pfizer 
Product Inc., an American pharmaceutical company. The GPO reasoned that the combination was not 
new and common for medical practices. Pfizer made a counterstatement denying the opposition that its 
invention was new and had an inventive step as the USPTO had already granted it a Patent No. 6455574. 
The Director-General agreed with Pfizer and ordered to reject the opposition. GPO appealed to the Board 
of Patents claiming that GPO and domestic pharmaceutical companies would find it hard to manufacture 
the same drug for Thai patients that would make the patients buy the drug in an expensive price if the 
Patent Office granted a patent to Pfizer. Moreover, Pfizer’s patent was removed some clauses by the 
USPTO which might refer to some flaws in the application. Nevertheless, the Board of Patents agreed 
that the invention of Pfizer was new and had an inventive step. Therefore, the Board upheld the decision 
of the Director.  
Also, in Decision No. 12/2553115, GPO made an opposition against a patent application of Bristol-
Myers Squibb Company (BMS), a global biopharmaceutical company headquartered in New York. In 
2003, BMS had applied for an invention patent for a method for treating HIV infection patients in 
Thailand, but the GPO opposed the application in 2006 on the grounds that the application was similar to 
an expired US patent and that the application was in conflict with Section 9(4) of the Patent Act.116 The 
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Director-General rejected the opposition based on the reason that the invention in the application was not 
new but had an inventive step. GPO appealed but the Board of Patents upheld the decision of the 
Director-General reasoning that the application had an inventive step from the US expired patent and the 
claims of the application were not in conflict with the Patent Act. 
Let us observe again that a result of these decisions, people in Thailand and other developing 
countries have to buy expensive drugs from foreign pharmaceutical companies although the majority of 
people cannot afford to buy those drugs. When pre-grant oppositions of pharmaceutical inventions fail, 
the unfair price is enacted in the citizens of developing countries falling sick and dying. Although the 
GPO can still appeal a decision of the Board of Patents to the Court, in the time between the petition and 
final ruling, the pressing needs of people who must maintain a drug regimen or otherwise have immediate 
access to medicine are not put on pause. In the past, the Thai Patent Act included provisions for 
pharmaceutical patents in Part VII but it was canceled entirely in 1999 due to Thailand’s accession to the 
TRIPs Agreement. The Patent Act should resume its exception section for medicines for the sake of 
public interest. If Thai government could bring back those provisions relating to medicines, it would be 
greatly beneficial to the Thai people.  
To sum up, an opposing party has a right to oppose a patent application in Thailand during a pre-grant 
opposition period but the opposition may not always succeed. The opposing party may have to appeal yet 
nothing guarantees that the appeal will be successful. The opposing party may use its last endeavor by 
bringing the dispute to the IP&IT Court but, also, nothing guarantees that the opposing party will also 
succeed in an opposition against the registration of a patent application. Finally, a situation may result in 
which an opposing party simply wastes time, effort and expense. Moreover, the 90-day period after the 
publication of an application may unfairly restrict the opportunity for anyone wishing to oppose an 
application. 
4.2. Successful Oppositions  
A successful opposition not only brings joy to an opposing party but can also strengthen business value 
and, in case of pharmaceutical patents, social justice. As claimed by Todd D. Clark in Pharma 
Handbook117, “a pre-grant opposition is shaping up to be the biggest impediment to patent 
issuance”.118Thus, when oppositions succeed during the pre-grant opposition period, they bolster the 
argument that Thailand has an efficient pre-grant opposition system, whose benefits are for the public at 
the end of the day.  
As mentioned, the process of opposition begins after publication of a patent application. Once 
opposed, an applicant can always make a counterstatement. If the Director-General orders to reject an 
application, an applicant can always appeal the order to the Board of Patents within the provided period. 
If an appeal of an opposing party is upheld, an application will be rejected. This can be counted as a 
successful opposition. On the other hand, if the Director-General orders to reject an opposition, an 
opposing party can appeal the order to the Board of Patents as well. The Board of Patents may decide to 
reverse the Director-General’s order. Consequently, an application will be rejected, which serves as a 
successful opposition as well. Either way, an opposition is successful. There have been many decisions 
like this. 
4.2.1. Applications rejected by the Director-General and the Board of Patents 
In 1997, in the Board of Patents’ decision No. 13/2540119, Mr. Kitti applied for a design patent for a tape 
cassette shelf but Mr. Chamras opposed the application, reasoning that the applied shelf was similar to his 
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patent. Accordingly, Mr. Chamras had already sold the patented shelves in a widespread manner long 
before the date of Mr. Kitti’s application. The design application featured a circle base while the design of 
the opposing party had a triangle base. Both designs were slightly different in height. The Director-
General decided that both designs were not sufficiently different and rejected the application. The 
applicant appealed the order of the Director-General to the Board of Patents, but the Board of Patents 
upheld the decision of the Director-General because the design in the application was similar to the 
design in the opposition to the degree that it was clear the applicant imitated the design in the opposition.  
Like the case of tape cassette shelf in 1997, in Decision No. 1/2542, 120an application for a refrigerator 
and compressor of refrigerant invention patent by Hitachi LTD was rejected by the Director-General and 
the Board of Patents respectively. However, this 1999 decision had two opposing parties: Sanyo 
Universal electric and Mrs. Samakkachan. The opposition by Sanyo Universal electric was rejected while 
the opposition by Mrs. Samakkachan was accepted. The reason for rejecting the application by the 
Director-General was that the applied invention was not new; as a matter of fact, it was a combination of 
existing inventions without adding new technology. As a result, the applied invention had no inventive 
step. Hitachi LTD appealed the decision of the Director to the Board of Patents but the Board also 
rejected the application on the same ground as the Director. 
These two decisions show the triumph of opposition in both the publication of application process and 
the appeal process. Ideally, it would be instantly apparent when an application had copied prior art and 
would thereby be immediately rejected by the Director. In reality, many applications waste both the time 
and money of the patent office and the opposing party, who are compelled to file an opposition although 
the infringing application will surely be rejected at the end once it has been thoroughly examined two or 
more times. 
4.2.2. Successful Appeals 
In Decision No.3/2541,121 dating from 1998, the opposition failed in the first stage but succeeded in the 
appeal stage. The decision involved a method of making a machinery joint for steel deformed bar in 
reinforced concrete. The applicant applied for a method of making a machinery joint that could stand the 
pulling and pressing of a steel deformed bar in a reinforced concrete while the opposing party opposed 
that the method was not new and had no inventive step. The Director-General considered evidence and 
ordered to reject the opposition because the applied machinery joint had a longer length for its ply than a 
normal joint, making it not obvious and possessing an inventive step. The opposing party appealed. The 
Board of Patents concluded that despite the inventive length of the joint’s ply, the method was still 
common for people with such skill. As a result, the method had no inventive step and the application was 
rejected. This decision shows how understanding technical function can be a problem for examiners, the 
Director-General, and the Board of Patents. If only there were a set standard for determining technical 
function, the Director and the Board would decide in the same way which can help to shorten the time for 
all parties. 
Decision No.1/2544122from 2001 reveals an opposition rejected by the Director-General because the 
opposing party did not submit enough supporting documentation. However, when the case reached the 
Board of Patents, the opposing party convinced the Board with additional evidence to make the 
opposition success in the appeal stage. The decision reflects that sufficient supporting documents are very 
essential in terms of whether an opposition fails or succeeds. In the decision, Kabushiki Kaisa Toshiba 
applied a patent for a refrigerator in 1990 but Universal Electric Public Co. Ltd. opposed that the 
invention was not new, as evidenced in its photo taken in 1989. Besides, the applied part was merely 
placement of an existing technology which did not add any difference to the preexisting function. 
Toshiba’s counterstatement argued that the invention was new because the photos and details were only 
disclosed to a small group of experts, not to the public. The Director-General decided in favor of Toshiba 
reasoned that both inventions were slightly different since Toshiba had improved some functions that 
were useful than previous one in the photo of Universal. Moreover, Universal did not show any evidence 
supporting its claim that the invention in the photo had already been manufactured or disclosed to the 
public in its substantial parts domestically or internationally. Nevertheless, Universal appealed to the 
Board of Patents. The Board of Patents rejected Toshiba’s application because Universal showed 
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evidence of manufacture and distribution of its similar refrigerator before Toshiba’s application date. 
Universal even offered the Board to bring a refrigerator and its parts to the patent office to show the 
likeness. Therefore, the Board concluded that the invention of Toshiba was not new. Similarly, in 
Decision No.10/2554123, the applicant had applied for a design patent for boots but the opposing party 
opposed it on the ground that it was not novel but was similar to its exported boots according to its 
catalogue. The Director-General rejected the opposition. Subsequently, the opposing party appealed the 
decision to the Board of Patents but the Board, after considering all evidence, decided that the boots in the 
application and the opposition and appeal were closely similar. The differences were not substantial 
enough to make the boots in the application new. Therefore, the Board rejected the application. 
These oppositions failed at first and succeeded at the end124. Besides looking at the results of an 
opposition, the reasons for failed or successful oppositions are also worth consideration. These reasons 
are varied and subjective depending on the Director’s and the Board’s discretion and documentation 
provided at each stage. Patent quality deriving from an opposition process also depends on discretion and 
supporting evidence as well. 
4.2.3. Group oppositions 
Sometimes an application is opposed by a number of opposing parties, similar to a class action in a court. 
The result of “group oppositions” tends to be rejection of the application because they demonstrate many 
people knew about the invention before patent registration. As such, the invention must not be novel. 
Registration of such invention would harm other inventors and interfere in their channel of trade.  
For example, in Decision No. 6/2544125covering a patent for a plastic bag, the application was 
opposed by five plastic bag factories since the technique for manufacturing a three-layer plastic bag were 
common and could be easily known by veterans in such area. The Director-General rejected five 
oppositions, and the application met its final rejection by the Board of Patents at the appeal. Echoing the 
former, Decision No. 29/2549126rejected a patent application after being opposed by three oppositions. 
The application’s subject matter was an improvement of the mechanical quality of a polyethylene pipe but 
three oppositions all claimed that such pipes were already widely produced according to EU and Japanese 
patents, which were referred to in the decision. Both Director-General and the Board of Patents agreed to 
reject the application because the pipe was not new and had no inventive step. 
4.2.4. Serial Oppositions 
The next group of oppositions is a series of oppositions by a person or company. Just like previous 
section, this type of opposition is normally between the same applicant and opposing party or vice versa 
such as an applicant becomes an opposing party or an opposing party turns to be an applicant in a latter 
decision. Generally, these people do the same business and produce same invention/design. Obviously, 
they are competitors. As a consequence, the grant of patent to other parties will lessen the business 
opportunities of another party since a patent is an exclusive right. Any method and documents that can 
oppose the registration of a patent application will be used. For example, in Decision No. 18/2549127, 
Mrs. Lerkvi-chiean opposed the registration of design patent application for a shoe by Bowling Shoe Co. 
Ltd., claiming that the company’s design application imitated a design of a shoe in an Italian shoe 
magazine published in 2001, although the application was made in 2002. Despite an argument that a 
design application was different from a shoe in the magazine, the Director-General and the Board of 
Patents decided to reject the application because the application and the shoe in the magazine was 
obviously a copy. Similarly, in Decision No., 19/2549128, Bowling Shoe Co. Ltd. also applied for a design 
patent for a shoe but Mrs. Lerkvi-chiean opposed the application again, claiming that the application was 
similar to a shoe in an Italian shoe magazine published one year prior to the application date. The 
differences between the application and the shoe in the magazine were minor. Although the applicant 
presented numerous reasons why the designs differed, the Director-General and the Board of Patents did 
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not agree with the applicant. The application was obviously seen as an imitation of a shoe in the 
magazine. As a result, the application was rejected.  
In our analysis, there must be a connection between Bowling Shoe Co. Ltd. and Mrs. Lerkvi-chiean in 
making consecutive oppositions. Through research on the Internet, the author has found that Mrs. Lerkvi-
chiean is in the shoe business, most recently in the capacity of director of Regent Street Co. Ltd., which 
manufactures rubber shoes.129 Therefore, we can conclude that both Bowling Shoe and Mrs. Lerkvi-
chiean are competitors and the registration of the shoe designed by the former can obstruct the business of 
the latter. Their serial oppositions are normal and understandable. 
As covered in our discussion of failed oppositions, D.T.C. Industries PLC made a series of 
unsuccessful oppositions. Anyway, D.T.C. had some luck that it could succeed in these oppositions. In 
Decision No. 15/2553130, D.T.C. opposed an industrial design invention of Mr. Suputipong involving a 
design for a ballpoint pen. D.T.C reasoned in the opposition that the design in the application was not new 
because it resembled disclosed designs to the degree it was apparent the application imitated the disclosed 
designs. The applicant countered that his application differed from the claimed design in both the handle 
and design of a pen. The Director-General rejected the opposition. However, D.T.C. appealed to the 
Board of Patents, insisting on the same claim but also pointing out to similar parts between the 
application and the disclosed designs. The Board considered all evidence and documents and finally 
agreed with D.T.C. that each part of the design in the application was similar to the disclosed designs. 
The application merely brought the design for a handle of a pen from one disclosed design and a design 
for a printed pattern of a pen from another to compose as a new design. Therefore, neither novelty nor an 
inventive step was found in the application. The Board of Patents reversed the decision of the Director-
General and decided to reject the application. Similarly, in decision No. 16/2553, Mr. Suputipong applied 
for an industrial design patent for a ballpoint pen. Again, D.T.C. opposed the application with the ground 
that the design was not new because such design was similar to Spanish patent No. 143629. The applicant 
countered that he had developed all designs by himself up to the point he decided to apply for a patent. 
With such a weighty counterstatement including his original design drawing, the Director-General 
decided to reject the opposition. As informer decisions, D.T.C. appealed by stressing the same reasons in 
the opposition but adding that the applicant developed nothing more than a copy of the existing designs of 
the handle, body and stopper of the pen in another design patent. The Board considered the appeal and 
agreed with D.T.C. that each part of a design in the application came from existing designs. As a result, 
the Board of Patents rejected the application. Once more, Mr. Suputipong applied for an industrial design 
patent for a ballpoint pen, but D.T.C. opposed the application on the ground that the application was 
similar to its design patents. The applicant’s counterstatement claimed he was the one who had researched 
and developed the design in the application. The Director-General was convinced by the applicant and 
rejected the opposition. D.T.C. appealed the decision to the Board of Patents, claiming that the design in 
the application was not new. The Board agreed with D.T.C. and rejected the application.  
From these three decisions involving the design of a ballpoint pen, it is not hard to guess that both the 
applicant and the opposing party are competitors, as our research proves. Mr. Suputipong is Managing 
Director of Nanmee Co. Ltd., a large stationary company in Thailand offering the brands Horse, Arrow, 
Nanmee and Max, while D.T.C. Industry PLC is also a dominant stationary company in Thailand offering 
several brands including Lancer. Securing a patent is another strategy to exclude competitors from the 
market since a patentee has an exclusive right. Consequently, competitors must raise every reason to 
oppose a patent application. The success or failure of an opposition depends on whether the reasons and 
supporting evidence are solid enough. The only suspicion left is why the Director-General and the Board 
of Patents decided the same dispute dissimilarly? Was it because of the individuals’ discretion or due to 
the Director or the Board’s connection to one of the companies? These questions are intriguing to know. 
Nonetheless, in 2009, four consecutive Board of Patents decisions featured the same applicant and an 
opposing-party were same persons for four Board of Patents’ decisions consecutively. All decisions were 
about the process of making pulp from tapioca waste or mixed tapioca waste. In a decision No. 1/2552131, 
Mr. Techaviboon applied for an invention patent for a process of making pulp from tapioca waste but the 
Cementhai Legal Counsel Limited (Cementhai) opposed the application reasoning that the process of 
making pulp from tapioca waste was simple and easy. The invention had no novelty and inventive step. 
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The Director-General rejected the application. Mr. Techaviboon appealed but the Board of Patents still 
agreed with reasons of the opposition. Although the use of pure tapioca waste increased the quality of 
pulp in paper by 10-20 percent, the process of making such pulp was too simple for people in paper 
industry. The Board of Patents upheld the decision of the Director-General, which was to reject the 
application. Similarly, in a decision No. 2/2552132, Cementhai opposed a patent application of Mr. 
Techaviboon again. The patent application involved a method of making pulp by adding pulp of tapioca 
waste to paper tissue during the process of manufacturing paper. The process of this invention was pretty 
similar to the application in a previous decision, but the latter invention was a slightly more complicated 
in adding pulp from tapioca waste to paper tissue during the pulping process. The Director rejected the 
application. In the appeal, Mr. Techaviboon tried to convince the Board of the complexity of the pulping 
process; nonetheless, the Board of Patents still rejected the application due to obviousness and lack of 
inventive step. 
Again, in a decision No. 3/2552,133 Mr. Techaviboon applied for a patent for mixed ingredients with 
tapioca waste to use in pulping process.  Cementhai Legal Counsel Limited opposed the application of 
Mr. Techaviboon for the third time. Once more, the Director rejected the application because of 
obviousness and no inventive step. Although Mr. Techaviboon appealed by claiming that other 
ingredients like pieces of paper and wood bits could improve quality of paper by ten to twenty percent, 
the Board still rejected the application by upholding the reasons of the Director. Even worse, there was no 
evidence of improvement as claimed by Mr. Techaviboon and no exact percentage of the ingredients was 
disclosed in the application either. Anyway, as Mr. Techaviboon had also applied for a patent for 
ingredients of tapioca waste to use in pulping process. Cementhai opposed that the application was 
common and was already disclosed in a book published before the application date. Repeatedly, a 
decision No. 4/2552134 showed that the Director-General rejected the application because of obviousness 
and no inventive step. The applicant appealed. The Board upheld the Director’s decision despite the 
ingredients being cheaper than normal materials for pulping process and less harmful to people’s health 
than other materials such as hay. The Board of Patents reasoned that the pulping process and the 
ingredients were too obvious for people in that field. Therefore, the application was not new and had no 
inventive step.  
All four decisions have the same applicant and opposing party for a closely similar invention 
involving with making pulp from tapioca waste. Cementhai is a legal company of Siam Cement Group 
Plc., which is a giant company that also, manufactures paper. If the applicant was granted a patent, SCG 
would be in trouble for manufacturing paper using simple methods because the methods in these 
applications were too obvious. As a consequence, the examples of Cementhai as an opposing party can 
confirm that an opposition process can help improving patent quality.  
4.2.5. Pharmaceutical opposition  
The most important category of opposition involves medicine. Such oppositions have wide effects on 
pharmaceutical companies, inventors, NGOs, patients and patients’ families because patented medicines 
are normally sold at prices too high for the majority of patients in Thailand, who are still poor. 
Developing countries typically do not have the resources to permit them to develop or invent medicines in 
a manner competitive with developed nations. According to human rights doctrine, it is unfair for citizens 
of these countries to pay expensive prices for patented drugs manufactured by companies based in 
developed countries. There are many examples of international pharmaceutical companies applying for 
patents for drugs that they intend to sell in Thailand at a high price; however, in many case, the 
companies’ applications have been opposed by individual patients, governmental organizations or NGO. 
For patients in Thailand, successful oppositions have secured justice, social benefits, and the essential 
right to have good treatment and prolong life. 
Our first example of an important pharmaceutical opposition involves a Thai mixed herbal medicine 
for AIDS patients. In 2004, decision No. 10/2547135 revealed that herbs used commonly could not be 
registered for a patent if the mixed formula for the medicine was not distinguished and inventive enough 
                                                 
132
 Decision of Thai Board of Patents No. 2/2552 
133
 Decision of Thai Board of Patents No. 3/2552 
134
 Decision of Thai Board of Patents No. 4/2552 
135
 Decision of Thai Board of Patents No. 10/2547 
  
 
   
  
W.  Puasiri 
   
 
246 
 
for an experienced person in that field. The applicant was Chulalongkorn University and the opposing 
party was Mr. Manoonwong. The University applied a patent for mixed herb formula for treatment of 
HIV/AIDS patients, but the application was opposed because the formula was published in several 
journals and patent applications and it was common knowledge to experienced Thai traditional doctors. 
The Director-General rejected the application because the formula had no inventive step or new healing 
result from mixing those herbs. The University appealed, yet the Board of Patents upheld the Director-
General’s decision for the same reasons. This decision has proved beneficial to HIV/AIDS patients since 
said patients can still find inexpensive medicinal herbs in a market unrestricted by any pharmaceutical 
company. Both the Director and the Board have done a good job protecting the social interest. 
Interestingly, the decisions below may in fact be a series of opposition relating to pharmaceutical 
patents for herb extracts. Decision No. 23/2549136 and Decision No. 16/2550137 showed that Mr. Vichai’s 
patent applications for Thai herbs were opposed by Muntana Panich Chiangmai Co. Ltd. and Smith 
Natural Co. Ltd. as the first and second opposing parties respectively. Decision No. 23/2549 covered a 
patent application for an abstract of Pucraria minifica and Butea superba in capsules, while Decision No. 
16/2550 was covered an abstract of Butea superba solely.  
In the first decision, after the application was opposed by the first and second opposing party, the 
Director-General rejected the second opposition because its arguments lacked clarity. However, the 
Director-General also rejected the application according to grounds in the first opposition since the 
applicant could not demonstrate that the invention had an inventive step. Both the applicant and the first 
opposing party appealed against the order of the Director. The applicant claimed his invention had an 
inventive step and the first opposing party argued that the invention not only had no inventive step but 
also had no novelty since the method of abstracting the herb was already published in medical textbooks. 
The Board finally decided to uphold the decision of the Director to reject the application of Mr. Vichai.  
In the latter decision, the applicant applied for an invention patent for products abstracted from Butea 
superba. The first opposing party claimed that to add calcium to the products did not show any inventive 
step and the application was too similar to an existing patent. The second opposing party also supported 
the opposition of the first opposing party. The Director-General considered all evidence and decided to 
reject the opposition based on the reasons that the application was new and had an inventive step. The 
first opposing party appealed, arguing that the applicant did not state clearly in the application how much 
calcium was added to the products, nor why. The Board of Patents ruled that the application did not 
comply with Section 17(3) and (4) of the Patent Act138 because the applicant did not describe the precise 
percentage of calcium in the products.  
By rejecting both applications of Mr. Vichai regarding Pueraria minifica or Butea superba extracts, 
the Board of Patents preserved these herbs for the use of millions of patients who need them and cannot 
afford the premium price for a patented product. As a result, the public can utilize value from the herbs’ 
extracts freely. Blocking common herbal treatments from being unfairly patented is a true public benefit 
oppositions can achieve. Therefore, for the sake of the public wellness, pre-grant oppositions should be 
maintained. 
The next group is a series of oppositions by the Government Pharmaceutical Organization (GPO) 
against foreign pharmaceutical companies. The first decision was in 2010 against InterMune Inc., a 
leading global biopharmaceutical company headquartered in Brisbane, California. In decision No. 
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1/2553139, InterMune Inc. applied for an invention patent in Thailand for chronic hepatitis C treatment 
methods for patients who had previously failed antiviral therapy. The GPO opposed the application 
because the method of treatment was in conflict with Section 9(4) of the Patent Act. The Director-General 
rejected the opposition but the Board of Patents rejected the application. The Board of Patents reasoned 
that the application conflicted with Section 9(4), which prohibits patents for methods of treating disease. 
The law was truly written for the public benefit. 
Additionally, in Decision No. 1/2554140, Novartis International AG, a Swiss pharmaceutical company, 
had applied for an invention patent in Thailand for an integration of an organic compound, but the GPO 
opposed the application, claiming that the invention was not new since it had already been disclosed in 
the US Patent No. 5952356 four years before the application was made. Although Novartis in its 
counterstatement argued that the invention had an inventive step and was not similar to the US patent, the 
Director-General still rejected the application. Novartis appealed by claiming that the invention was not 
like any invention produced before because its integration caused an unexpected result with HMG-Co A 
reductase inhibitors, which was very beneficial in combating high blood pressure. Fortunately, the Board 
of Patents did not agree with Novartis, but instead reasoned that the invention was not new as disclosed in 
the US patent and patent application. Moreover, it ruled the unexpected result as claimed by Novartis did 
not exist. No improved result was found. Therefore, the Board rejected the appeal of Novartis. 
Although these were serial oppositions by the GPO, they were still successful and benefitted for the 
Thai public by protecting its access to inexpensive medicines, thereby serving as model oppositions for 
other developing countries. Above all, related governmental organizations must work forcefully and 
efficiently to protect the social interest; whether oppositions succeed or fail depends on the opposing 
party be able to search for prior art and draft an effective and complete opposition.  
To sum up, the process of opposition is necessary in any patent registration system. Not only can it 
reveal poor patent quality, but it also can protect social benefits. Developing countries must have a patent 
opposition system; in particular, Thailand’s pre-grant opposition successes show that the pre-grant 
opposition system seems to be best suited for developing and underdeveloped. 
4.3. Court cases resulting from opposition 
There have been several appeals brought to the Central Intellectual Property and International Trade 
Court (CIPITC) and to the Intellectual Property and International Trade division of the Supreme Court 
(IP&IT Court) challenging the Board of Patent’s decision to reject or grant a patent. The most recognized 
patent opposition case brought to the Court in Thailand involved a suit in 1999 against the Department of 
Intellectual Property (DIP) regarding its grant of a patent to Bristol-Myers Squibb (BMS) for the 
antiretroviral drug Didanosine (DDI). It may have been that the opposing parties did not manage to file a 
pre-grant opposition within 90 days from the publication of the application date and thus had to file a 
lawsuit after the grant of patent or that the opposing parties did not know about the application until the 
grant of patent. 
The AIDS Access Foundation, a Thai AIDS foundation, and two AIDS patients were plaintiffs while 
Bristol-Myers Squibb (BMS) and the Department of Intellectual Property were the defendant and co-
defendant respectively. The story began when BMS had applied for a patent for DDI in the U.S. and in 
Thailand. However, since DDI was not new at the applied date, BMS added an antacid to include 
inventive step in order to be able to apply for a patent. While DDI was in the process of consideration for 
a patent in the U.S., BMS was granted a patent for DDI in Thailand without limitation under the 
formulation range of 5mg to 100mg per dosage unit despite BMS having indicated in its application that 
BMS applied for just 5mg to 100mg per dosage unit. As a result, it was forbidden for any dosage of DDI 
to be manufactured in Thailand except with the consent of the patent holder BMS. Moreover, the GPO, 
the main health support organization in Thailand, was prohibited from producing DDI to sell at an 
inexpensive price to the Thai people. Consequently, the poor could not access DDI, leading to a number 
of AIDS fatalities in Thailand.141 
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The Court found later ordered DIP to annul the limitation of specified dosage range in BMS’s patent 
application. Although the cancellation of the limitation could be done upon discretion of the Director-
General, granting such a patent was unethical since it endangered the lives of Thai AIDS patients and 
forced them to pay a high price for DDI, a generic drug. The Court, therefore, ordered BMS and DIP to 
amend the patent by putting back the limitation of dosage 5mg to 100mg. The GPO was then able to 
produce cheaper DDI at dosages above 100 mg for HIV/AIDS patients. The Court has proven to be a true 
supporter of the people of Thailand who suffer from unfairness especially in the case of essential 
requisites like medicine. 
The next case also involves medicine, specifically Thai traditional medicine. Again, this case was not 
an appeal of the Board of Patents’ decision since the Patent Office had already granted a patent to the 
defendant. In the Supreme Court’s decision No. 4783/2549142, Khaolaor Pharmacy Partnership Ltd. 
(Khaolaor) and others were plaintiffs and Muntana Panich Chiangmai Co. Ltd. (Muntana) and others 
were defendants. In the case, both plaintiffs and defendants manufactured and sold modern medicine, 
traditional medicine, Chinese medicine, cosmetics, and supplementary food that had Pueraria mirifica as 
an ingredient. On August, 1999, Muntana announced on a daily newspaper (in Thai) that  
Muntana Panich Chiangmai Co. Ltd is the patentee of a Thai patent No. 8912 for products that have 
Pueraria mirifica as an ingredient. If anyone is manufacturing, selling, having for sale, or offering for 
sale products that have Pueraria mirifica as an ingredient, that person shall cease and desist such act and 
recall all products that violate the patent from the market immediately.”  
The plaintiffs examined the publication of the defendants’ patent application and found that the 
invention of the defendants was not new because it was already disclosed since 1931. With those claims, 
the plaintiffs sued DIP for granting of the invalid patent and sued the defendants for infringing the 
plaintiffs’ rights and causing damages to the plaintiffs. The plaintiffs requested the Court to revoke the 
patent No. 8912. The defendants’ essential testimony was that (1) the plaintiffs had no right to file a 
lawsuit, (2) the lawsuit was illegal, and (3) the invention was new and had never been disclosed anywhere 
before the application date. Nonetheless, the Court revoked the patent because the patent was invalid. 
Afterwards, the defendants appealed the Court’s decision to the Supreme Court. The Supreme Court 
opined that the invention was not new and had no inventive step since the use of Pueraria mirifica in 
products had been common in Thailand for a long time. Besides, the plaintiffs had lawful right to file a 
lawsuit against the defendants because they were in the same business. Therefore, the Supreme Court 
decided to uphold the decision of the Court.143 
In the decisions of the Court and the Supreme Court above, the judges focused more on the factors of 
the patentable subject. Once the judges compare the disclosed document with the patent application, the 
similarities between these documents made the Supreme Court judges decide that the patent was not 
novel, leading to a revocation of the patent. Moreover, the use of Pueraria mirifica in products is quite 
common in Thailand since it is a traditional herb whose pharmaceutical qualities are widely known, a fact 
which the judges were likely aware. In any case, the supporting evidence made the uncomplicated for the 
judges. Decisions like these prevent unfair competition from would-be patentees as it blocks them from 
dominating Pueraria mirifica market. As such, patent opposition, even in the Court, still can control 
patent quality and serve to balance competition as well. 
Lastly, the Supreme Court Decision No. 8993/2547144covering an invention patent for a condenser 
and refrigerant compressor is worthy of consideration. In this appeal case resulting from a decision of the 
Board of Patents to reject the patent, the Supreme Court decided to uphold the decision of the Court to 
cancel the decisions of the Board of Patents and the Director-General, who were defendants. The story 
began when Hitachi Ltd. had applied for an invention patent for condenser and refrigerant compressor but 
found itself facing two oppositions. The Director-General decided to reject the application because the 
invention was not new and had no inventive step. The Board of Patents also upheld the decision of the 
Director-General. However, Hitachi subsequently appealed the decision of the Board of Patents to the 
Court. The Court ruled on 16 October 2000 that Hitachi’s Patent Application No. 014866 was a new 
invention that also had an inventive step. Therefore, the Court canceled the decision of the Board of 
Patents and ordered the Director-General to permit the patent application to the next stage. The 
defendants in the Court appealed the judgment to the Supreme Court, claiming that the invention in the 
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application was not new and had no inventive step. As mentioned, the Supreme Court agreed otherwise 
and ordered to cancel the decision of the Board of Patents and proceed the patent application to the next 
stage. 
From the judgment we see that oppositions do not only serve to prohibit patent registration, but also 
act as a procedure which promotes fairness for both the applicant and the opposing party, as Hitachi. One 
of the parties may lose during opposition procedure, but because of the appeal procedure to the Court and 
the Supreme Court, such party can restore his lawful right.  
In the author’s opinion, the pre-grant opposition system and the appeal procedure to the Central 
Intellectual Property and International Trade Court and to the Supreme Court, division of Intellectual 
Property and International Trade suit the patent registration system in Thailand perfectly. Nonetheless, 
while the system is good, it would benefit from the hire of more officers and judges expert in a variety of 
subject matter. The discretion of patent examiners, patent committees, the Director-General, and the 
Board of Patents are tremendously essential to the fairness of the patent registration system. Furthermore, 
quality patent agents and lawyers are also in need as half of patent lawsuits are dismissed in the Central 
Intellectual Property and International Trade Court due to a lack of intellectual property knowledge and 
inexperience on the part of the agents and lawyers.145 
5. Effectiveness of the opposition procedure in Thailand 
In most developing countries, trade channels are narrow regardless of the type of product. This is because 
business operators in such countries are comparatively few in proportion to the population. For any 
business in Thailand, the market is small and competition scarce. At most, there are merely five or six 
businesses offering the same products in the same market. Since competition is not as great as in larger 
and more developed countries, the chance for a monopoly or business cartel are great. Dominant 
companies in the market can also abuse their power in order to grant a patent grant. Thus, it is essential 
for a patent office to have strong quality control before granting any patent. Yet, the number of examiners 
in a patent office may be insufficient to examine the validity of the components of an invention. Pre-grant 
opposition can help with this issue in obstructing invalid patents through the help of other persons apart 
from examiners in a patent office. 
From the examples above, an opposition in Thailand may or may not succeed depending on discretion 
of the Director-General, the Board of Patents, the Central Intellectual Property and International Trade 
Court, and also on the capability of the opposition to present a convincing argument. Analyses of how 
pre-grant opposition in Thailand controls patent quality efficiently is subjective yet must depend on the 
factual basis of each case. As analyzed in Part 4, pre-grant oppositions by interested persons have stopped 
the grant of a bad quality patents in many instances. These pre-grant oppositions can win relatively 
effortlessly if an application is clearly invalid and an opposing party can prove that. Part 4 proves that 
Thai patent officers are efficient enough to consider each opposition and its appeal justly. For example, 
the GPO has succeeded many times via pre-grant opposition to defend the public interest in generic drugs 
from companies that have sought for patent for them. Moreover, Thailand has an excellent specialized 
court system in intellectual property law. The system does not have a procedure in the Court of Appeal 
which enables a plaintiff to appeal directly to the Supreme Court from the Central Intellectual Property 
and International Trade Court.  
However, oppositions in Thailand are not always successful. The main reasons for failed pre-grant 
opposition in Thailand as analyzed in Part 4 are (1) poorly prepared documents and insufficient evidence 
and claims, (2) inexperienced patent agents or lawyers, (3) unpredictable discretion of officers, (4) 
evidence of foreign registered patents, and (5) influence of large companies. There are also random 
reasons for failed patent oppositions such as an obscured employment contract146, inability of the 
Director-General and the Board of Patents to count the 90-day period from a publication date correctly147 
and negligence of examiners to remove a dosage claim from essential medicines.  
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Regarding the current efficiency of pre-grant opposition in Thailand, the 90 days period is an 
adequate minimum of time to make an opposition. This is because if the period were longer, it would 
prolong the grant of patent, adversely affecting applicants’ rights. If a patent is truly invalid, any person 
can challenge the invalidity and revoke such patent with the patent office or the Court. The author is 
satisfied with pre-grant opposition in Thailand as of now. Yet there is room for improvement in 
performance. Firstly, the author suggests related authorities to set up a standard for similarity between 
prior arts and an invention in an application. Clearly establishing a set of rules and regulations for 
determining technical, chemical, and biological functions are also necessary for examiners to decide the 
validity of an invention according to the same standards. Patent applications should be published in 
famous daily newspapers to access a wide enough audience to get the attention of any potential opponents 
of an application because the opposition must be done strictly within 90 days after the publication. 
Finally, the author suggests the Department of Intellectual Property recruit more experienced examiners 
in order to check prior arts and scrutinize the validity of patent applications more efficiently. Enacting 
these suggestions will improve the quality of pre-grant opposition in Thailand, which will lead to an 
improvement of patent quality as well. 
It must be stressed here that the patent registration procedure must have an opposition process to 
control patent quality. The lack of an opposition procedure can lead to a tremendous number of 
revocations and lawsuits to a patent office and the Court. Moreover, it will lead to a quick process of 
granting a patent; yet many patents will be granted carelessly and will prove to have bad quality in the 
end. It is wrong for anyone to be granted a patent when the patent is in fact invalid. In addition, a pre-
grant opposition can help terminate an application before a grant of a patent if an obvious invention is 
applied for a patent. Likewise, it is extremely essential to improve the quality of examiners and officers in 
the patent office from time to time as well as recruit more specialists to examine each application. Pre-
grant opposition by interested persons or prosecutors is necessary, especially in developing countries 
where a balance between the rights of inventors and public benefit must be well maintained. Therefore, in 
Thailand, the pre-grant opposition procedure can be counted as a strong mechanism to scrutinize a patent 
application by any interested person before an examination procedure by examiners. 
6. Tendency of patent opposition system in Thailand 
When an applicant applies for a patent, any interested person can oppose the patent application within 90 
days after a publication of the patent application. Thereafter, an applicant may make a counterstatement 
against the opposition. After that, the Director-General will make a decision either to reject the opposition 
or reject the application. Any party that does not agree with the decision of the Director-General has a 
right to appeal the decision to the Board of Patents. These opposition processes are handled within the 
Patent Office. Therefore, in each decision of Thai Board of Patents, there are two parts: (1) decisions of 
the Director-General, and (2) decisions of the Board of Patents.  
From information kindly given by the legal office of the Department of Intellectual Property, the 
author has composed a table of decisions for petty patents, decisions with oppositions from interested 
persons, and decisions in which the Director-General ordered to reject patent applications without 
oppositions from interested persons. The Board of Patents decisions that the author includes cover the 
period from 1995 to 2011. In total, there are 255 decisions but with just 80 decisions that have 
oppositions from interested persons. Each year, decisions of the Board of Patents with oppositions from 
interested persons can be divided as the table below. 
 
 
 
 
 
                                                                                                                                               
 The applicant applied a patent for a pile rig. The application was opposed based on a reason that the 
opposing party’s patent was infringed. However, the opposition was rejected by the Director-General because the 
opposing party did not oppose within 90 days from the date of publication of the application. The opposing party 
appealed and the Board found that the opposition was filed within 90 days of the publication date but the application 
did not infringe the patent of the opposing party because the rig in the application was not similar to the patented rig. 
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Table of Decisions of the Board of Patents with Oppositions from Interested Parties, 
1995 to 2011 
 
 
From the table above, the number of decisions with oppositions is much lower than the total number 
of decisions that the Board of Patent has decided per year. For example, in 1996 and 1997, decisions with 
oppositions represented only two decisions out of fourteen and nineteen decisions respectively. 
Furthermore, there was no decision with oppositions by interested persons at all from 2002 through 2003. 
One could argue that it was a period that Thailand had just recovery from the economic crisis. The 
situation resulted as no patent oppositions filed, nor any design patents granted because business 
entrepreneurs focused only on maintaining their business after the collapsing economy. The number of 
decisions with oppositions by interested persons has risen again from 2004 onwards. Especially in 2010, 
the total number of decisions with oppositions reached twenty-four, with design patent applications 
representing those most opposed. 
On the other hand, in separating the table according to decisions of the Director-General and the 
Board of Patents, the research finds that most patent oppositions failed in the Director-General round as 
compared to appeals in the Board of Patents round. This information indicates that a typical opposing 
party may not yet be ready with supporting documentation and convincing evidence when the Director-
General makes a decision, but they prepare better for the decision of the Board of Patents. As a result, the 
number of successful oppositions in the Board of Patents round is higher than the number of successful 
oppositions in the Director-General round. In the same way, the numbers of failed oppositions in the 
Director-General round are more than numbers of failed oppositions in the Board of Patents round. From 
the record, the author generates a graph for decisions in the Director-General round and a graph for 
decisions in the Board of Patent round from year 1995 to year 2011 per the below. 
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The graph above shows that successful design patent oppositions are trending upwards, although the 
numbers of successful oppositions lessened a bit in 2011. The dip may be due a decrease in the total 
number of patent oppositions presented before the Board. Failed design patent oppositions are also on the 
rise as well, but their average is lower than for successful design patent oppositions. Nevertheless, both 
failed and successful invention patent oppositions have fallen continuously since 2006. Therefore, the 
tendency is that the number of invention patent oppositions will continue to be lower than the number of 
design patent oppositions in the Director-General round. Also, it seems that failed invention and design 
patent oppositions will continue to increase in the Director-General round. The Director-General tends to 
reject oppositions rather than patent applications. 
  
 
 
Additionally, the graph above shows that from 2005 onwards, successful design patent oppositions 
have increased tremendously compared to failed design patent oppositions. This trend should continue for 
a couple of years due to the promotion of a design patent by the Thai Research Fund and DIP. In the same 
way, the number of successful invention patent oppositions has fallen since 2006, but the numbers of 
successful invention patent oppositions are still higher than the number of failed invention patent 
oppositions in the Board of Patents round. It seems that the Board of Patents will continue to decide in 
favor of patent oppositions and reject patent applications, regardless whether they are invention or design 
patents. 
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7. Concluding remarks 
As R. Polk Wagner has stated, “There is perhaps no patent issue with a higher profile than the question of 
patent quality.”148 Poor patent quality can have many negative consequences, as we explore above. 
Improving patent quality via the opposition system is a method with proven successes. However, the 
results depend on many factors, such as the patent registration system and its enforcement in each country 
and economic circumstance. Also, the question as to whether pre-grant or post-grant opposition is better 
is difficult to answer. Different countries may have different results even if they adopt the same type of 
opposition. As such, pre-grant patent opposition in Thailand is studied as an example. Thorough research 
found that pre-grant opposition system in Thailand has proven worthy of its enactment because the 
system prevents many low quality patents as well as defends public interest via different means, 
especially in the case of pharmaceutical patents. The research indicates that pre-grant patent opposition, 
with or without post-grant opposition, is well-suited for Southeast Asian countries like Thailand mainly 
because of its low cost and the likelihood of abuse of the post-grant opposition system in which the grant 
of patent can be canceled. Moreover, the pre-grant opposition system can maintain social benefits for 
majority of Thai people who are still poor and need aid from developed countries, not advantage-taking. 
Undoubtedly, pre-grant opposition is essential for the Thai patent registration system because it serves to 
balance the country’s private and public int interests. 
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